{"gene":"XPA","run_date":"2026-06-11T09:02:06","timeline":{"discoveries":[{"year":1994,"finding":"XPA protein is a zinc metalloprotein that binds preferentially to UV-, cisplatin-, and OsO4-damaged DNA; a cysteine residue (Cys-103) in the C4-type zinc finger motif is indispensable for normal protein conformation and DNA-binding/NER activity, as shown by site-directed mutagenesis.","method":"Bacterially expressed recombinant XPA protein; nitrocellulose filter-binding assay for damaged DNA; atomic absorption and UV-CD spectroscopy; site-directed mutagenesis of Cys-103; microinjection complementation assay","journal":"Mutation research","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution with mutagenesis plus functional complementation, replicated across multiple methods in a single study","pmids":["7526200"],"is_preprint":false},{"year":1994,"finding":"XPA and ERCC1 specifically interact both in vivo (yeast two-hybrid) and in vitro (recombinant proteins); the interaction domains were initially mapped, suggesting XPA recruits the ERCC1-containing incision complex to damaged DNA.","method":"Yeast two-hybrid system; in vitro binding with recombinant proteins; domain mapping","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal in vivo and in vitro methods, replicated in multiple subsequent studies","pmids":["8197174"],"is_preprint":false},{"year":1994,"finding":"XPA forms a ternary complex with ERCC1 and ERCC4(XPF) heterodimer; an XPA affinity column depletes excision activity from HeLa extracts, which is restored by the XPA-bound fraction; the bound fraction complements ERCC1, ERCC4/XPF, and XPA-deficient extracts.","method":"XPA affinity column chromatography; in vitro complementation assay with cell-free extracts from repair-deficient cell lines","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstitution with affinity chromatography and functional complementation; independently replicated","pmids":["8197175"],"is_preprint":false},{"year":1995,"finding":"XPA interacts with both the 70-kDa and 34-kDa subunits of RPA at distinct sites; the RPA70-interaction domain maps to XPA residues 153–176, and deletion mutants within this region are deficient in RPA binding and highly defective in NER both in vitro and in vivo; the XPA–RPA complex has greater affinity for damaged DNA than XPA alone.","method":"In vitro binding assays; yeast two-hybrid; deletion mutagenesis; in vitro NER assay; in vivo complementation of XPA-deficient cells","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — mutagenesis combined with in vitro and in vivo functional assays; replicated across methods","pmids":["7565690"],"is_preprint":false},{"year":1995,"finding":"XPA mutations that delete the G motif (Gly-72–Phe-75) or E motif (Glu-78–Glu-84) prevent association with ERCC1 and fail to complement XPA-deficient extracts in NER; the delta-G mutant acts as a dominant negative in wild-type extracts, indicating that the XPA–ERCC1 interaction is required for NER.","method":"Site-specific mutagenesis; in vitro ERCC1-binding assay; in vitro DNA repair synthesis assay; in vivo complementation","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — mutagenesis with multiple functional readouts; dominant-negative result confirms mechanistic requirement","pmids":["7891694"],"is_preprint":false},{"year":1995,"finding":"XPA interacts with the 34-kDa subunit of RPA, as identified by yeast two-hybrid; the RPA complex (70/34/11 kDa) associates with XPA, suggesting cooperation in early NER steps.","method":"Yeast two-hybrid; co-association with RPA complex","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — yeast two-hybrid plus biochemical co-association; single lab but corroborated by concurrent studies","pmids":["7876167"],"is_preprint":false},{"year":1995,"finding":"Enhancement of XPA's damaged-DNA binding by ERCC1; XPA–ERCC1 interaction requires a stretch of consecutive glutamic acid residues in XPA; ERCC1 does not enhance binding when the truncated XPA-MF122 (lacking the protein–protein interaction region) is used.","method":"In vitro binding assay; yeast two-hybrid; electrophoretic mobility shift assay with truncation mutants","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct binding and truncation analysis in a single lab with two orthogonal methods","pmids":["7598728"],"is_preprint":false},{"year":1996,"finding":"The damaged-DNA binding domain of XPA is contained within residues 98–219 (MF122 fragment), which includes a C4-type zinc finger motif and has helix-rich secondary structure; this domain is sufficient for preferential binding to UV- or cisplatin-damaged DNA.","method":"Truncation analysis; nitrocellulose filter-binding assay; circular dichroism spectroscopy","journal":"Mutation research","confidence":"High","confidence_rationale":"Tier 1 / Strong — domain mapping with biophysical structural confirmation and functional binding assay","pmids":["8538652"],"is_preprint":false},{"year":1996,"finding":"RPA and ERCC1 bind XPA at non-overlapping regions; a ternary RPA–XPA–ERCC1 complex forms in vitro; sequential binding occurs with RPA (KD ~19 nM) binding before ERCC1 (KD ~250 nM) based on surface plasmon resonance.","method":"In vitro binding/truncation assays; surface plasmon resonance biosensor; detection of ternary complex","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1 / Moderate — SPR kinetics plus domain mapping; single lab but rigorous biophysical methods","pmids":["8972858"],"is_preprint":false},{"year":1997,"finding":"TFIIH has some affinity for DNA but unlike XPA does not prefer UV-damaged DNA; TFIIH binds to XPA·DNA complexes in a UV damage-dependent manner via direct protein–protein interaction, suggesting XPA recruits TFIIH to damage sites.","method":"Filter binding assays; pull-down experiments; TFIIH interaction with XPA·DNA complexes","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pull-down and filter binding with both undamaged and UV-damaged DNA substrates; single lab","pmids":["9287294"],"is_preprint":false},{"year":2000,"finding":"RPA32 C-terminal globular domain interacts with XPA (and UNG2, RAD52) through a common structural surface; NMR structures of RPA32C free and in complex with UNG2 define the shared binding interface, establishing a structural basis for XPA recruitment by RPA.","method":"NMR structure determination; binding assays with XPA, UNG2, RAD52","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — NMR structure with functional binding validation across multiple repair proteins","pmids":["11081631"],"is_preprint":false},{"year":2000,"finding":"XPA interacts with the novel cytoplasmic GTPase XAB1; XAB1 binds the N-terminal region of XPA (residues 30–34 required for nuclear localization); deletion of residues 30–34 abolishes XAB1 interaction, implicating XAB1 in nuclear import of XPA.","method":"Yeast two-hybrid screen of HeLa cDNA library; deletion mapping; immunofluorescence","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — yeast two-hybrid plus deletion analysis and localization data; single lab","pmids":["11058119"],"is_preprint":false},{"year":2000,"finding":"RPA stabilizes the XPA–damaged DNA complex through protein–protein interaction; wild-type RPA enhances XPA binding to (6-4) photoproduct-containing DNA, whereas a mutant RPA (p34Δ33C) defective in XPA interaction fails to stabilize this complex.","method":"Surface plasmon resonance analysis; mutant RPA lacking XPA interaction domain","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — SPR with specific domain-disrupting mutant; rigorous biophysical approach","pmids":["10828957"],"is_preprint":false},{"year":2001,"finding":"XPA–RPA complex acts as a double-check sensor: XPA binds rigidly bent duplexes (backbone distortion) via indirect readout, while RPA recognizes single-stranded regions (base pair disruption); together they simultaneously detect backbone and base pair distortion, supporting a damage-verification/assembly role rather than direct lesion recognition.","method":"DNA binding assays with substrates containing mispaired bases, non-hybridizing analogues, and artificially bent duplexes; electrophoretic mobility shift assays","journal":"The EMBO journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — systematic substrate analysis with engineered DNA structures; single lab, multiple orthogonal substrates","pmids":["11432842"],"is_preprint":false},{"year":2002,"finding":"XPA forms a homodimer (XPA2) in solution under normal conditions; the dimer, not the monomer, forms the complex with RPA; XPA contains post-translational modifications as indicated by mass spectrometry.","method":"Native gel filtration chromatography; native PFO-PAGE; fluorescence spectroscopy; mass spectrometry; baculovirus-expressed protein","journal":"Biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple biophysical methods in a single lab; single study","pmids":["12390028"],"is_preprint":false},{"year":2002,"finding":"XPA contacts both the damaged and undamaged strands of a damaged duplex DNA, while RPA binds preferentially to the undamaged strand; demonstrated using photoreactive base analogues in specific substrates for site-specific crosslinking.","method":"Site-specific photocrosslinking with photoreactive base analogues; strand-specific analysis","journal":"Biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — site-specific crosslinking with chemically defined substrates; single lab","pmids":["11841234"],"is_preprint":false},{"year":2003,"finding":"In the presence of XPA, RPA binds specifically to the undamaged strand of CPD-containing duplex DNA, whereas without XPA both strands are bound non-specifically; this strand-specific interaction is relevant for guiding XPG/XPF nucleases to the correct cleavage sites.","method":"NMR spectroscopy with RPA-A and RPA-AB domains; CPD-containing duplex DNA substrates","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — NMR structural analysis with defined damaged substrates; single lab","pmids":["12907715"],"is_preprint":false},{"year":2005,"finding":"XPA binds damaged DNA cooperatively: at lower concentrations as a monomer, at higher concentrations as a dimer; the dimer is the dominant form for efficient damage binding, with a Hill coefficient of ~1.9 and stepwise binding constants determined; RPA presence does not substantially enhance overall binding efficiency.","method":"Gel mobility shift assay; gel filtration chromatography; UV-crosslinking; fluorescence spectroscopy; competitive binding assay","journal":"Biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal biochemical methods; single lab","pmids":["15882075"],"is_preprint":false},{"year":2007,"finding":"Crystal structure of ERCC1 bound to an XPA peptide shows that only a small region of XPA interacts with ERCC1 with submicromolar affinity; this XPA peptide is a potent inhibitor of NER activity in a cell-free excision assay; the structure defines the XPA–ERCC1 binding interface.","method":"Crystal structure determination; fluorescence anisotropy binding assay; cell-free NER excision assay with peptide inhibitor","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure plus functional inhibition assay; rigorous structural and biochemical validation","pmids":["17948053"],"is_preprint":false},{"year":2008,"finding":"DDB directly interacts with XPA primarily through the DDB2 subunit; XPA residues 185–226 are important for this interaction; the point mutation R207G in XPA disrupts DDB interaction in vitro and in vivo, abrogates DDB-stimulated CPD excision in a reconstituted system, and reduces XPA recruitment to damage sites in cells.","method":"In vitro binding assays; co-immunoprecipitation; site-directed mutagenesis (R207G); cell-free NER excision assay; in vivo repair assays","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1 / Strong — mutagenesis with multiple in vitro and in vivo functional readouts in a single rigorous study","pmids":["19056823"],"is_preprint":false},{"year":2010,"finding":"SIRT1 interacts with XPA, and this interaction is enhanced after UV irradiation; SIRT1 deacetylates XPA at Lys-63 and Lys-67 both in vitro and in cells; hyperacetylated XPA (K63/67Q mimetic) is NER-defective and shows increased UV sensitivity; SIRT1-mediated deacetylation of XPA enhances XPA–RPA32 interaction.","method":"Co-immunoprecipitation; in vitro deacetylation assay; XPA K63Q/K67Q acetylation-mimetic mutants; UV survival assay; in vivo NER assay","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro enzymatic assay plus mutagenesis with multiple functional readouts in cells","pmids":["20670893"],"is_preprint":false},{"year":2010,"finding":"XPA protein undergoes circadian oscillation in mouse liver (but not testis) regulated at the transcriptional level by core circadian clock proteins including cryptochrome, and at the post-translational level by HERC2 ubiquitin ligase; consequently, cisplatin-adduct repair in liver extracts shows a circadian pattern.","method":"Immunoblotting of mouse liver/testis extracts at circadian time points; in vitro excision repair assays; analysis of cryptochrome and HERC2 role","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo biochemistry in mouse tissues plus functional repair assays with circadian regulation demonstrated","pmids":["20304803"],"is_preprint":false},{"year":2010,"finding":"XPA is a rate-limiting factor for NER in all human cell lines tested; its level is regulated post-translationally by the HECT-domain E3 ubiquitin ligase HERC2; DNA damage promotes tight association of XPA with chromatin and dissociation from HERC2, thereby inhibiting XPA ubiquitination and degradation; XPA is acetylated but in mouse liver only a small fraction is acetylated.","method":"siRNA knockdown of HERC2 and XPA; Tet-regulatable XPA expression; co-immunoprecipitation; chromatin fractionation; repair assays","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods including knockdown, regulated expression, co-IP, and functional repair assays","pmids":["21193487"],"is_preprint":false},{"year":2012,"finding":"ATR phosphorylates XPA at Ser-196, enhancing XPA stability by inhibiting HERC2-mediated ubiquitination and degradation; S196A (phosphodeficient) mutant shows persistent HERC2 association and enhanced ubiquitination; S196D (phosphomimetic) shows reduced HERC2 binding and delayed degradation; ATR-mediated phosphorylation also enhances chromatin retention of XPA and its interaction with binding partners after DNA damage.","method":"Site-directed mutagenesis (S196A, S196D); co-immunoprecipitation; ubiquitination assay; chromatin fractionation; XPA-deficient cell complementation","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 1 / Strong — phosphomimetic and phosphodeficient mutagenesis with multiple functional readouts; single rigorous study","pmids":["23178497"],"is_preprint":false},{"year":2012,"finding":"XPA contains a functional PCNA-interacting motif (APIM); XPA colocalizes with PCNA in replication foci and is loaded on newly synthesized DNA in undamaged cells; XPA-deficient cells complemented with APIM-mutant XPA show increased UV sensitivity, reduced CPD and (6-4) photoproduct repair, and increased S-phase arrest; TFIIH subunit XPD and XPF are also loaded on DNA together with XPA.","method":"Live cell imaging; PCNA co-localization; XPA APIM mutagenesis; UV survival and repair assays in XPA-/- cells; chromatin loading assays","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mutagenesis combined with functional repair and localization assays; single lab","pmids":["23152873"],"is_preprint":false},{"year":2014,"finding":"XPA binds poly(ADP-ribose) (PAR) non-covalently via specific basic amino acids in a conserved PAR-binding motif that overlaps the DDB2 and TFIIH interaction domains; XPA–PAR interaction lowers XPA's DNA-binding affinity; XPA strongly stimulates PARP1 enzymatic activity; PARP inhibition alters XPA-GFP recruitment to laser-induced DNA damage sites.","method":"PAR-binding assays with XPA mutants; biochemical PARP1 activity assay; live-cell microirradiation with XPA-GFP; co-immunoprecipitation","journal":"The FEBS journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (biochemical, live imaging) in single lab","pmids":["24953096"],"is_preprint":false},{"year":2014,"finding":"Defective mitophagy in XPA-deficient cells is caused by PARP-1 hyperactivation leading to decreased NAD+–SIRT1–PGC-1α axis activity; PARP-1 inhibition or NAD+ precursor supplementation rescues mitochondrial defects and lifespan in xpa-1 nematodes; this nuclear-mitochondrial crosstalk pathway is absent in XPC (NER-deficient without neurodegeneration).","method":"In silico analysis; in vivo XPA-deficient cells and xpa-1 C. elegans; PARP inhibitor treatment; NAD+ supplementation; mitochondrial membrane potential assays","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic and pharmacological rescue experiments in multiple systems; high citation independent replication evidence","pmids":["24813611"],"is_preprint":false},{"year":2014,"finding":"Redefined DNA-binding domain of XPA extends to residue 239 (XPA 98–239), not residue 219 as previously reported; XPA(98–239) binds Y-shaped ssDNA/dsDNA junction with the same affinity as full-length XPA; the construct undergoes a conformational change upon DNA binding.","method":"Fluorescence anisotropy DNA-binding assay; 2D 15N-1H NMR; C-terminal extension series of XPA constructs","journal":"Journal of the American Chemical Society","confidence":"High","confidence_rationale":"Tier 1 / Moderate — NMR plus quantitative binding assay with multiple constructs; redefines prior domain boundaries","pmids":["25056193"],"is_preprint":false},{"year":2015,"finding":"XPA activates unwinding of normal DNA by TFIIH Core7 but inhibits Core7 helicase activity in the presence of bulky lesions; bulky lesions inhibit XPB and XPD ATPase/helicase activities to promote NER; XPA, XPC, and TFIIH constitute a tripartite lesion verification mechanism.","method":"Reconstitution of human ten-subunit TFIIH and Core7; ATPase and helicase activity assays with defined substrates; NER assays with defined lesions","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — full biochemical reconstitution with purified homogeneous TFIIH; in vitro enzymatic assays with rigorous controls","pmids":["26384665"],"is_preprint":false},{"year":2018,"finding":"SIRT1 deacetylates XPA at Lys-63, Lys-67, and Lys-215 to promote XPA interactions with ATR; acetylation mimetics at these residues blunt UV-dependent ATR–XPA interaction even in the presence of cAMP; ATR-mediated phosphorylation of XPA at Ser-196 enhances cAMP-mediated NER and is promoted by SIRT1-mediated deacetylation.","method":"Co-immunoprecipitation; acetylation-mimetic and phosphomimetic/deficient mutants; UV-damage repair assays; cAMP signaling manipulation","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mutagenesis with functional repair readouts; single lab, extends prior SIRT1/XPA findings","pmids":["30327428"],"is_preprint":false},{"year":2020,"finding":"Two distinct interaction surfaces between XPA and RPA organize the NER preincision complex: (1) XPA N-terminal disordered domain with RPA32C, and (2) XPA DNA-binding domain with RPA70AB; mutations disrupting either site reduce NER activity, and combining both mutations additively inhibits NER; integrative structural modeling places the NER bubble in a U-shape with the two ssDNA/dsDNA junctions in proximity.","method":"NMR mapping of binding interfaces; X-ray scattering; comprehensive docking and refinement; XPA mutations inhibiting RPA70AB interaction; biochemical and cellular NER assays","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1 / Strong — NMR plus SAXS plus mutagenesis plus functional NER assays; multiple orthogonal methods","pmids":["31925419"],"is_preprint":false},{"year":2022,"finding":"Both XPA–RPA interaction sites (XPA-N/RPA32C and XPA-DBD/RPA70AB) are functionally required for NER; mutations in either site reduce NER in biochemical and cellular systems; combining mutations in both sites is additive; the XPA-N–RPA32C contact is important for initial XPA association with NER complexes, while XPA-DBD–RPA70AB contact organizes the complex for dual incision; the NER bubble assumes a U-shape geometry.","method":"Site-directed mutagenesis; in vitro NER biochemical assays; cell-based NER assays; integrative structural modeling with SAXS and NMR data","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Strong — mutagenesis with biochemical reconstitution and cellular functional assays; multiple orthogonal methods","pmids":["35969784"],"is_preprint":false},{"year":2023,"finding":"Cryo-EM structures reveal that XPA binds between XPB and XPD helicases of TFIIH Core7 and kinks the DNA duplex; this shifts XPC and the DNA lesion by nearly a helical turn relative to Core7, positioning the lesion outside Core7 for verification; XPB and XPD track the lesion-containing strand in opposite directions, pushing and pulling it into XPD for verification.","method":"Cryo-EM structure determination of human XPC–TFIIH–XPA–DNA complexes","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 / Strong — cryo-EM structures directly show XPA positioning within NER complexes at high resolution","pmids":["37076618"],"is_preprint":false},{"year":2006,"finding":"UV-induced ATR signaling (ATRIP translocation to UV damage sites, Chk1 phosphorylation, RPA phosphorylation and chromatin binding) is compromised in XPA-deficient human cells during S phase, but not in XPC-, CSB-, XPF-, or XPG-deficient cells; the lesion-recognition function of XPA (not damage processing) is sufficient for ATR-mediated S-phase checkpoint activation.","method":"Immunofluorescence for ATRIP translocation; western blotting for Chk1 and RPA phosphorylation; chromatin fractionation in NER-factor-deficient human cell lines","journal":"The EMBO journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — epistasis analysis across multiple NER-deficient cell lines with defined molecular readouts; single lab","pmids":["16675950"],"is_preprint":false},{"year":2009,"finding":"Cep164 is recruited to CPD sites in a UV-dependent manner requiring XPA; UV irradiation enhances the physical interaction between Cep164 and XPA; Cep164 binds XPA residues 4–97; XPA(Δ10-88) mutant cells show aberrant Cep164/CPD co-localization and impaired UV-induced CHK1 phosphorylation.","method":"Co-immunoprecipitation; chromatin immunoprecipitation; immunofluorescence co-localization; XPA deletion mutants; CHK1 phosphorylation assay","journal":"Cell cycle (Georgetown, Tex.)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP plus deletion mapping plus functional checkpoint readout; single lab","pmids":["19197159"],"is_preprint":false},{"year":2014,"finding":"RASSF1A forms a DNA damage-regulated complex with XPA and is required for full XPA repair activity; RASSF1A-deficient cells have impaired DNA repair; a cancer-associated RASSF1A SNP shows differential XPA binding and inhibits repair; RASSF1A and its SNP variant differentially regulate XPA acetylation and modulate the XPA–RPA70 complex.","method":"Co-immunoprecipitation; DNA repair assays in RASSF1A-deficient cells; SNP variant binding analysis; acetylation assays","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP with functional repair readout and SNP analysis; single lab","pmids":["25368379"],"is_preprint":false},{"year":2000,"finding":"Nickel(II), Cd(II), Co(II), and Cu(II) reduce XPA's DNA-binding ability; simultaneous treatment with Zn(II) largely prevents inhibition by Cd(II), Co(II), and Ni(II); Ni(II) does not form the same tetrahedral zinc finger complex as Zn(II).","method":"Nitrocellulose filter-binding assay for XPA activity; Zn(II) competition experiments","journal":"Carcinogenesis","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct in vitro activity assay with metal competition; single lab","pmids":["11062174"],"is_preprint":false},{"year":2003,"finding":"Ni(II) substitutes Zn(II) in the XPA zinc finger peptide (XPAzf) forming a square planar complex; this abolishes the normal tetrahedral zinc finger structure; Ni(II)-substituted XPAzf is highly susceptible to oxidative damage by H2O2; binding constants for Zn(II)/Ni(II) differ by ~800–2300-fold.","method":"Fluorescence spectroscopy; UV-vis and CD spectroscopy; HPLC oxidative damage analysis; synthetic XPAzf peptide","journal":"Chemical research in toxicology","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro biophysical characterization with synthetic zinc finger peptide; single lab, rigorous spectroscopic methods","pmids":["12588196"],"is_preprint":false},{"year":1991,"finding":"XPA protein (xpac) is localized in the nucleus of human cells; two forms (~40 and ~38 kDa) are detected; reduced or absent protein in XP group A cells correlates with repair defect severity; protein level does not increase after UV irradiation.","method":"Antibody against recombinant xpac protein; SDS-PAGE/immunoblotting; indirect immunofluorescence","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct protein detection with specific antibody in normal and XP cells; single lab","pmids":["1918083"],"is_preprint":false},{"year":2001,"finding":"Full-length Xenopus XPA (xXPA) contains ordered internal core (residues ~Q85–I179) and disordered N- and C-terminal regions; mass spectrometry confirms no post-translational modifications in this species; xXPA binds cisplatin-modified ± mismatch DNA with at least 10-fold higher affinity than unmodified DNA.","method":"Time-resolved trypsin proteolysis; ESI-FTICR mass spectrometry; gel filtration chromatography; PONDR disorder prediction","journal":"Protein science","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — mass spectrometry with proteolysis; rigorous structural characterization of Xenopus XPA; single lab","pmids":["11420437","11344324"],"is_preprint":false},{"year":2001,"finding":"DDB stimulates in vitro excision of CPDs (but not 6-4 photoproducts) in a reconstituted NER system; DDB elevates XPA binding to damaged DNA and forms a complex with damaged DNA together with XPA or XPA+RPA; the stimulation requires both XPA and RPA.","method":"In vitro NER excision assay; electrophoretic mobility shift assay; DNase I protection assay; addition of recombinant proteins to cell-free extracts","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reconstituted in vitro system with multiple protein combinations and lesion-specific assays; single lab","pmids":["11278856"],"is_preprint":false}],"current_model":"XPA functions as a central scaffold in the nucleotide excision repair (NER) pre-incision complex: it is a zinc metalloprotein with a C4-type zinc finger domain that binds preferentially to structurally distorted/damaged DNA via indirect readout of DNA backbone bending; it recruits the ERCC1–XPF endonuclease through a specific interaction with ERCC1 (mediated by XPA's G and E motifs), recruits TFIIH through direct protein–protein contact, and organizes the complex with RPA through two distinct interaction surfaces (XPA N-terminus/RPA32C and XPA DBD/RPA70AB); cryo-EM structures show XPA binding between XPB and XPD in TFIIH to kink the DNA and position the lesion for XPD-mediated verification; XPA's level and activity are regulated by HERC2-mediated ubiquitination/degradation (antagonized by ATR-mediated Ser-196 phosphorylation upon DNA damage), by SIRT1-mediated deacetylation at Lys-63/67/215 (which promotes ATR interaction and RPA32 binding), by PARP1-generated poly(ADP-ribose) (which lowers XPA's DNA affinity and is reciprocally stimulated by XPA), and by circadian-clock-driven transcription; additionally, XPA-deficient cells show defective mitophagy caused by PARP-1 hyperactivation and NAD+/SIRT1 reduction, revealing a nuclear-mitochondrial crosstalk role beyond direct DNA repair."},"narrative":{"mechanistic_narrative":"XPA is the central scaffold of the nucleotide excision repair (NER) pre-incision complex, a zinc metalloprotein whose C4-type zinc finger (requiring Cys-103) is essential for proper folding and preferential binding to UV-, cisplatin-, and OsO4-damaged DNA [PMID:7526200, PMID:8538652]. Rather than directly reading the lesion, XPA recognizes structurally distorted/bent duplex DNA through indirect backbone readout, while its partner RPA recognizes the disrupted base-paired strand, forming a combined damage-verification sensor; XPA contacts both damaged and undamaged strands and RPA enforces strand-specific binding that orients the XPF and XPG nucleases [PMID:11432842, PMID:11841234, PMID:12907715]. XPA assembles the incision machinery through defined protein contacts: its G and E motifs bind the ERCC1–XPF endonuclease (a contact required for NER and exploited as a peptide inhibitor) [PMID:7891694, PMID:17948053], it recruits TFIIH to damaged DNA in a damage-dependent manner [PMID:9287294], and it organizes RPA through two distinct surfaces—an N-terminal disordered region engaging RPA32C and its DNA-binding domain engaging RPA70AB—that together fold the NER bubble into a U-shaped geometry [PMID:31925419, PMID:35969784]. Within TFIIH, XPA binds between the XPB and XPD helicases and kinks the DNA, repositioning the lesion outside Core7 so that XPB and XPD track the damaged strand in opposite directions to drive XPD-mediated lesion verification [PMID:26384665, PMID:37076618]. XPA is a rate-limiting NER factor whose abundance and activity are tightly regulated: HERC2 ubiquitin ligase targets XPA for degradation, antagonized by ATR-mediated Ser-196 phosphorylation upon damage, while SIRT1 deacetylates XPA at Lys-63/67/215 to promote ATR interaction and RPA32 binding, and circadian clock control drives oscillation of XPA-dependent repair [PMID:20670893, PMID:21193487, PMID:23178497, PMID:30327428, PMID:20304803]. XPA also engages PARP1—binding poly(ADP-ribose), which lowers its DNA affinity, while reciprocally stimulating PARP1 activity—and beyond direct repair, XPA loss causes PARP-1 hyperactivation that depletes NAD+/SIRT1 and impairs mitophagy, revealing nuclear–mitochondrial crosstalk [PMID:24953096, PMID:24813611]. XPA further contributes to ATR-dependent S-phase checkpoint activation through its lesion-recognition function [PMID:16675950].","teleology":[{"year":1991,"claim":"Established that XPA is a nuclear protein whose loss correlates with the severity of the repair defect in xeroderma pigmentosum group A cells, anchoring the gene to NER capacity.","evidence":"Specific antibody immunoblotting and immunofluorescence in normal and XP-A cells","pmids":["1918083"],"confidence":"Medium","gaps":["Did not define molecular activity","Two protein forms not mechanistically explained","No partner identified"]},{"year":1994,"claim":"Answered how XPA recognizes damage and showed it is a metal-dependent damage sensor, defining the zinc finger as essential for conformation and DNA-binding/NER activity.","evidence":"Recombinant XPA filter-binding, spectroscopy, Cys-103 mutagenesis, and microinjection complementation","pmids":["7526200"],"confidence":"High","gaps":["Mechanism of lesion discrimination not resolved","Did not localize the minimal DNA-binding domain"]},{"year":1994,"claim":"Identified XPA as the recruiter of the ERCC1–XPF incision complex, establishing a scaffold function beyond passive damage binding.","evidence":"Yeast two-hybrid, in vitro binding, affinity-column depletion/complementation with repair-deficient extracts","pmids":["8197174","8197175"],"confidence":"High","gaps":["Interaction interface mapped only coarsely","Order of complex assembly not defined"]},{"year":1995,"claim":"Demonstrated that the XPA–ERCC1 contact through the G and E motifs is mechanistically required for NER, with a dominant-negative deletion confirming necessity.","evidence":"Site-specific mutagenesis with in vitro repair synthesis and in vivo complementation","pmids":["7891694","7598728"],"confidence":"High","gaps":["Atomic interface not yet defined","Functional consequence for nuclease positioning unknown at this stage"]},{"year":1995,"claim":"Established XPA–RPA as a cooperative damage-binding pair, mapping the RPA70-interaction region and showing the complex binds damaged DNA more tightly than XPA alone.","evidence":"In vitro and yeast two-hybrid binding, deletion mutagenesis, in vitro and in vivo NER assays","pmids":["7565690","7876167"],"confidence":"High","gaps":["Structural basis of RPA contact not yet resolved","Stoichiometry of the complex undefined"]},{"year":1996,"claim":"Localized XPA's damaged-DNA binding to residues 98–219 and showed RPA and ERCC1 bind non-overlapping regions in a kinetically ordered ternary complex.","evidence":"Truncation analysis, CD spectroscopy, filter-binding, and surface plasmon resonance kinetics","pmids":["8538652","8972858"],"confidence":"High","gaps":["Domain boundary later revised","Order of assembly within the full complex still incomplete"]},{"year":1997,"claim":"Showed XPA recruits TFIIH to damage sites, since TFIIH binds XPA·DNA complexes in a UV-damage-dependent manner despite lacking intrinsic damage preference.","evidence":"Filter binding and pull-down with damaged and undamaged DNA substrates","pmids":["9287294"],"confidence":"Medium","gaps":["TFIIH-contacting residues of XPA not mapped","Single-lab evidence without structural detail"]},{"year":2000,"claim":"Provided structural and mechanistic basis for RPA-mediated recruitment and stabilization of XPA, and linked XPA to nuclear import via the GTPase XAB1.","evidence":"NMR of RPA32C, SPR with XPA-interaction-defective RPA mutant, yeast two-hybrid screen with deletion mapping","pmids":["11081631","10828957","11058119"],"confidence":"High","gaps":["XAB1 evidence is Medium-confidence single lab","Full architecture of XPA–RPA on DNA still unresolved"]},{"year":2001,"claim":"Defined XPA–RPA as a double-check sensor detecting backbone bending and base-pair disruption simultaneously, recasting XPA as a verification/assembly factor rather than a lesion reader.","evidence":"EMSA with mispaired, non-hybridizing, and artificially bent DNA substrates; DDB stimulation of CPD excision in reconstituted NER","pmids":["11432842","11278856"],"confidence":"Medium","gaps":["Indirect-readout model based on engineered substrates","DDB stimulation lesion-specificity mechanism unresolved"]},{"year":2002,"claim":"Resolved the strand topology of XPA binding (both strands contacted) versus RPA (undamaged strand) and indicated XPA functions as a homodimer in the RPA complex.","evidence":"Site-specific photocrosslinking; native gel filtration, PFO-PAGE, and mass spectrometry","pmids":["11841234","12390028"],"confidence":"Medium","gaps":["Oligomeric state in the full NER complex contested","Functional role of dimerization not established in vivo"]},{"year":2003,"claim":"Showed XPA confers strand specificity on RPA binding at CPD lesions, providing the basis for correct positioning of dual-incision nucleases.","evidence":"NMR with RPA-A/AB domains on CPD-containing duplex substrates","pmids":["12907715"],"confidence":"Medium","gaps":["Direct link to nuclease cleavage geometry inferred, not shown","Single-lab structural study"]},{"year":2007,"claim":"Defined the atomic XPA–ERCC1 interface and validated its functional importance by showing the XPA peptide inhibits NER.","evidence":"Crystal structure of ERCC1–XPA peptide, anisotropy binding, and cell-free excision inhibition","pmids":["17948053"],"confidence":"High","gaps":["Structure limited to an isolated peptide","Context within the full complex not captured"]},{"year":2008,"claim":"Connected XPA to the global-genome damage-recognition factor DDB2, mapping a C-terminal interaction whose R207G disruption impairs damage recruitment and repair.","evidence":"In vitro binding, co-IP, R207G mutagenesis, reconstituted excision, and in vivo recruitment/repair assays","pmids":["19056823"],"confidence":"High","gaps":["Temporal handoff from DDB to XPA not fully ordered","Overlap with PAR/TFIIH binding region not yet recognized at this stage"]},{"year":2010,"claim":"Established post-translational and circadian control of XPA abundance, identifying HERC2-mediated degradation, SIRT1-mediated deacetylation enhancing repair, and clock-driven oscillation of NER.","evidence":"Co-IP, in vitro deacetylation, acetylation-mimetic mutants, HERC2 knockdown, chromatin fractionation, and circadian-time tissue immunoblotting","pmids":["20670893","20304803","21193487"],"confidence":"High","gaps":["Upstream signals triggering HERC2 dissociation only partly defined","Tissue specificity of circadian control unexplained"]},{"year":2012,"claim":"Identified ATR phosphorylation of XPA at Ser-196 as the switch that stabilizes XPA upon damage by blocking HERC2-mediated ubiquitination, and linked XPA to replication via a PCNA-interacting motif.","evidence":"S196A/S196D mutagenesis, co-IP, ubiquitination and chromatin assays; APIM mutagenesis with UV survival/repair and live imaging","pmids":["23178497","23152873"],"confidence":"High","gaps":["APIM/replication role is Medium-confidence single lab","Crosstalk between phosphorylation and acetylation not integrated"]},{"year":2014,"claim":"Connected XPA to PARP1 signaling and revealed a non-canonical role: XPA loss drives PARP-1 hyperactivation depleting NAD+/SIRT1 and impairing mitophagy, defining nuclear–mitochondrial crosstalk.","evidence":"PAR-binding mutants, PARP1 activity assays, microirradiation; rescue by PARP inhibition/NAD+ in XPA-deficient cells and C. elegans; RASSF1A complex co-IP and repair assays","pmids":["24953096","24813611","25368379"],"confidence":"High","gaps":["RASSF1A regulation is Medium-confidence single lab","Mechanistic basis of neurodegeneration specific to XPA loss not fully resolved"]},{"year":2014,"claim":"Refined the XPA DNA-binding domain to residues 98–239 and showed it binds Y-shaped ss/ds junctions with full-length affinity, undergoing a DNA-induced conformational change.","evidence":"Fluorescence anisotropy and 2D NMR with a C-terminal extension construct series","pmids":["25056193"],"confidence":"High","gaps":["Functional contribution of the extended region in cells not isolated","Conformational change not yet mapped onto complex assembly"]},{"year":2015,"claim":"Defined XPA's role in lesion verification by showing it activates TFIIH unwinding of normal DNA but inhibits Core7 helicase at bulky lesions, forming a tripartite verification system with XPC and TFIIH.","evidence":"Reconstituted ten-subunit TFIIH/Core7 ATPase and helicase assays with defined lesions","pmids":["26384665"],"confidence":"High","gaps":["Structural arrangement of XPA within TFIIH not yet visualized at this stage"]},{"year":2020,"claim":"Resolved the two-surface architecture by which XPA organizes RPA (XPA-N/RPA32C and XPA-DBD/RPA70AB), folding the NER bubble into a U-shape required for activity.","evidence":"NMR, SAXS, integrative modeling, and RPA70AB-disrupting mutations with biochemical and cellular NER assays","pmids":["31925419"],"confidence":"High","gaps":["Atomic-resolution structure of the assembled bubble not yet available","Role of each contact in assembly order partly inferred"]},{"year":2022,"claim":"Assigned distinct functions to the two XPA–RPA contacts: XPA-N/RPA32C for initial complex association and XPA-DBD/RPA70AB for organizing dual incision, with additive effects when both are disrupted.","evidence":"Site-directed mutagenesis with in vitro and cell-based NER assays plus integrative SAXS/NMR modeling","pmids":["35969784"],"confidence":"High","gaps":["Precise temporal ordering of incision events not directly observed"]},{"year":2023,"claim":"Provided the high-resolution structural mechanism: XPA binds between XPB and XPD and kinks the DNA to reposition the lesion for XPD verification, with the two helicases tracking the strand in opposite directions.","evidence":"Cryo-EM of human XPC–TFIIH–XPA–DNA complexes","pmids":["37076618"],"confidence":"High","gaps":["Dynamics of lesion handoff to incision not captured","Regulatory modifications not visualized in the structure"]},{"year":null,"claim":"How XPA's regulatory modification network (HERC2/ATR/SIRT1/PARP1) is integrated with the structurally defined pre-incision complex to control repair timing in vivo remains unresolved.","evidence":"","pmids":[],"confidence":"High","gaps":["No structure of modified XPA within an assembled complex","Quantitative ordering of regulation versus assembly steps in cells undefined","Mechanistic basis of XPA-specific neurodegeneration via mitochondrial crosstalk incomplete"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,7,13,15,27]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[2,4,8,9,30,31]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[25,28]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[38,11]},{"term_id":"GO:0000228","term_label":"nuclear chromosome","supporting_discovery_ids":[22,23]}],"pathway":[{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[2,4,28,30,32]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[33,23]},{"term_id":"R-HSA-9909396","term_label":"Circadian clock","supporting_discovery_ids":[21]}],"complexes":["NER pre-incision complex","XPA–RPA complex","XPA–ERCC1–XPF complex","XPC–TFIIH–XPA–DNA complex"],"partners":["ERCC1","RPA70","RPA32","TFIIH","DDB2","SIRT1","HERC2","PARP1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P23025","full_name":"DNA repair protein complementing XP-A cells","aliases":["Xeroderma pigmentosum group A-complementing protein"],"length_aa":273,"mass_kda":31.4,"function":"Involved in DNA nucleotide excision repair (NER). Initiates repair by binding to damaged sites with various affinities, depending on the photoproduct and the transcriptional state of the region. Required for UV-induced CHEK1 phosphorylation and the recruitment of CEP164 to cyclobutane pyrimidine dimmers (CPD), sites of DNA damage after UV irradiation (PubMed:19197159). During NER stimulates the 5'-3' helicase activity of XPD/ERCC2 and the DNA translocase activity of XPB/ERCC3 (PubMed:31253769). Connects XPD/ERCC2 and XPB/ERCC3 during NER, retaining DNA near the XPB/ERCC3 active site, and stabilizing the complex in a different conformation than in transcribing TFIIH (PubMed:31253769)","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/P23025/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/XPA","classification":"Not Classified","n_dependent_lines":8,"n_total_lines":1208,"dependency_fraction":0.006622516556291391},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"CDC7","stoichiometry":10.0},{"gene":"CDK7","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/XPA","total_profiled":1310},"omim":[{"mim_id":"616093","title":"BLOOD GROUP, ABO SYSTEM","url":"https://www.omim.org/entry/616093"},{"mim_id":"615919","title":"ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2","url":"https://www.omim.org/entry/615919"},{"mim_id":"614848","title":"CENTROSOMAL PROTEIN, 164-KD; CEP164","url":"https://www.omim.org/entry/614848"},{"mim_id":"614248","title":"PEAK FAMILY MEMBER 1; PEAK1","url":"https://www.omim.org/entry/614248"},{"mim_id":"613208","title":"XPC COMPLEX SUBUNIT, DNA DAMAGE RECOGNITION AND REPAIR FACTOR; XPC","url":"https://www.omim.org/entry/613208"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nuclear bodies","reliability":"Supported"},{"location":"Nucleoplasm","reliability":"Additional"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/XPA"},"hgnc":{"alias_symbol":["XPAC","XP1"],"prev_symbol":[]},"alphafold":{"accession":"P23025","domains":[{"cath_id":"3.90.530.10","chopping":"104-202","consensus_level":"medium","plddt":95.75,"start":104,"end":202},{"cath_id":"-","chopping":"243-273","consensus_level":"medium","plddt":83.8874,"start":243,"end":273}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P23025","model_url":"https://alphafold.ebi.ac.uk/files/AF-P23025-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P23025-F1-predicted_aligned_error_v6.png","plddt_mean":81.38},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=XPA","jax_strain_url":"https://www.jax.org/strain/search?query=XPA"},"sequence":{"accession":"P23025","fasta_url":"https://rest.uniprot.org/uniprotkb/P23025.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P23025/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P23025"}},"corpus_meta":[{"pmid":"24813611","id":"PMC_24813611","title":"Defective mitophagy in XPA via PARP-1 hyperactivation and NAD(+)/SIRT1 reduction.","date":"2014","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/24813611","citation_count":578,"is_preprint":false},{"pmid":"8040325","id":"PMC_8040325","title":"Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapy.","date":"1994","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/8040325","citation_count":380,"is_preprint":false},{"pmid":"7675086","id":"PMC_7675086","title":"Increased susceptibility to ultraviolet-B and carcinogens of mice lacking the DNA excision repair gene XPA.","date":"1995","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/7675086","citation_count":344,"is_preprint":false},{"pmid":"8197174","id":"PMC_8197174","title":"Specific association between the human DNA repair proteins XPA and ERCC1.","date":"1994","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/8197174","citation_count":278,"is_preprint":false},{"pmid":"10074455","id":"PMC_10074455","title":"Defective repair of cisplatin-induced DNA damage caused by reduced XPA protein in testicular germ cell tumours.","date":"1999","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/10074455","citation_count":248,"is_preprint":false},{"pmid":"7565690","id":"PMC_7565690","title":"An interaction between the DNA repair factor XPA and replication protein A appears essential for nucleotide excision repair.","date":"1995","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/7565690","citation_count":226,"is_preprint":false},{"pmid":"11081631","id":"PMC_11081631","title":"Structural basis for the recognition of DNA repair proteins UNG2, XPA, and RAD52 by replication factor RPA.","date":"2000","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/11081631","citation_count":214,"is_preprint":false},{"pmid":"20304803","id":"PMC_20304803","title":"Circadian control of XPA and excision repair of cisplatin-DNA damage by cryptochrome and HERC2 ubiquitin ligase.","date":"2010","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/20304803","citation_count":188,"is_preprint":false},{"pmid":"20670893","id":"PMC_20670893","title":"SIRT1 regulates UV-induced DNA repair through deacetylating XPA.","date":"2010","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/20670893","citation_count":185,"is_preprint":false},{"pmid":"8197175","id":"PMC_8197175","title":"Formation of a ternary complex by human XPA, ERCC1, and ERCC4(XPF) excision repair proteins.","date":"1994","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/8197175","citation_count":183,"is_preprint":false},{"pmid":"15095299","id":"PMC_15095299","title":"Reduced levels of XPA, ERCC1 and XPF DNA repair proteins in testis tumor cell lines.","date":"2004","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/15095299","citation_count":177,"is_preprint":false},{"pmid":"7876167","id":"PMC_7876167","title":"DNA repair protein XPA binds replication protein A (RPA).","date":"1995","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7876167","citation_count":169,"is_preprint":false},{"pmid":"11062174","id":"PMC_11062174","title":"Differential effects of toxic metal compounds on the activities of Fpg and XPA, two zinc finger proteins involved in DNA repair.","date":"2000","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/11062174","citation_count":154,"is_preprint":false},{"pmid":"11432842","id":"PMC_11432842","title":"Double-check probing of DNA bending and unwinding by XPA-RPA: an architectural function in DNA repair.","date":"2001","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/11432842","citation_count":148,"is_preprint":false},{"pmid":"15882455","id":"PMC_15882455","title":"ABCC5, ERCC2, XPA and XRCC1 transcript abundance levels correlate with cisplatin chemoresistance in non-small cell lung cancer cell lines.","date":"2005","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/15882455","citation_count":145,"is_preprint":false},{"pmid":"7526200","id":"PMC_7526200","title":"The XPA protein is a zinc metalloprotein with an ability to recognize various kinds of DNA damage.","date":"1994","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/7526200","citation_count":137,"is_preprint":false},{"pmid":"26384665","id":"PMC_26384665","title":"Tripartite DNA Lesion Recognition and Verification by XPC, TFIIH, and XPA in Nucleotide Excision Repair.","date":"2015","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/26384665","citation_count":134,"is_preprint":false},{"pmid":"9045683","id":"PMC_9045683","title":"A sequence in the N-terminal region of human uracil-DNA glycosylase with homology to XPA interacts with the C-terminal part of the 34-kDa subunit of replication protein A.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9045683","citation_count":134,"is_preprint":false},{"pmid":"17948053","id":"PMC_17948053","title":"Structural basis for the recruitment of ERCC1-XPF to nucleotide excision repair complexes by XPA.","date":"2007","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/17948053","citation_count":129,"is_preprint":false},{"pmid":"12509265","id":"PMC_12509265","title":"Cell type-specific hypersensitivity to oxidative damage in CSB and XPA mice.","date":"2003","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/12509265","citation_count":117,"is_preprint":false},{"pmid":"7891694","id":"PMC_7891694","title":"Mutations in XPA that prevent association with ERCC1 are defective in nucleotide excision repair.","date":"1995","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/7891694","citation_count":113,"is_preprint":false},{"pmid":"11420437","id":"PMC_11420437","title":"Aberrant mobility phenomena of the DNA repair protein XPA.","date":"2001","source":"Protein science : a publication of the Protein Society","url":"https://pubmed.ncbi.nlm.nih.gov/11420437","citation_count":106,"is_preprint":false},{"pmid":"12949838","id":"PMC_12949838","title":"Critical DNA damage recognition functions of XPC-hHR23B and XPA-RPA in nucleotide excision repair.","date":"2003","source":"Molecular carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/12949838","citation_count":102,"is_preprint":false},{"pmid":"21193487","id":"PMC_21193487","title":"Regulation of nucleotide excision repair activity by transcriptional and post-transcriptional control of the XPA protein.","date":"2010","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/21193487","citation_count":101,"is_preprint":false},{"pmid":"11972036","id":"PMC_11972036","title":"Human XPA and RPA DNA repair proteins participate in specific recognition of triplex-induced helical distortions.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/11972036","citation_count":98,"is_preprint":false},{"pmid":"11278954","id":"PMC_11278954","title":"Triplex-induced recombination in human cell-free extracts. Dependence on XPA and HsRad51.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11278954","citation_count":97,"is_preprint":false},{"pmid":"9287294","id":"PMC_9287294","title":"DNA damage recognition by XPA protein promotes efficient recruitment of transcription factor II H.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9287294","citation_count":96,"is_preprint":false},{"pmid":"11344324","id":"PMC_11344324","title":"Identification of intrinsic order and disorder in the DNA repair protein XPA.","date":"2001","source":"Protein science : a publication of the Protein Society","url":"https://pubmed.ncbi.nlm.nih.gov/11344324","citation_count":96,"is_preprint":false},{"pmid":"27247238","id":"PMC_27247238","title":"XPA: A key scaffold for human nucleotide excision repair.","date":"2016","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/27247238","citation_count":93,"is_preprint":false},{"pmid":"8538652","id":"PMC_8538652","title":"Identification of a damaged-DNA binding domain of the XPA protein.","date":"1996","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/8538652","citation_count":91,"is_preprint":false},{"pmid":"8972858","id":"PMC_8972858","title":"Sequential binding of DNA repair proteins RPA and ERCC1 to XPA in vitro.","date":"1996","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/8972858","citation_count":84,"is_preprint":false},{"pmid":"16675950","id":"PMC_16675950","title":"Opposing effects of the UV lesion repair protein XPA and UV bypass polymerase eta on ATR checkpoint signaling.","date":"2006","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/16675950","citation_count":80,"is_preprint":false},{"pmid":"9359827","id":"PMC_9359827","title":"The DNA damage-recognition problem in human and other eukaryotic cells: the XPA damage binding protein.","date":"1997","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/9359827","citation_count":79,"is_preprint":false},{"pmid":"11278856","id":"PMC_11278856","title":"Damaged DNA-binding protein DDB stimulates the excision of cyclobutane pyrimidine dimers in vitro in concert with XPA and replication protein A.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11278856","citation_count":79,"is_preprint":false},{"pmid":"16413230","id":"PMC_16413230","title":"XPA protein as a limiting factor for nucleotide excision repair and UV sensitivity in human cells.","date":"2006","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/16413230","citation_count":73,"is_preprint":false},{"pmid":"1372103","id":"PMC_1372103","title":"Identification of splicing mutations of the last nucleotides of exons, a nonsense mutation, and a missense mutation of the XPAC gene as causes of group A xeroderma pigmentosum.","date":"1992","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/1372103","citation_count":72,"is_preprint":false},{"pmid":"37076618","id":"PMC_37076618","title":"Lesion recognition by XPC, TFIIH and XPA in DNA excision repair.","date":"2023","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/37076618","citation_count":67,"is_preprint":false},{"pmid":"12588196","id":"PMC_12588196","title":"Mechanism of nickel assault on the zinc finger of DNA repair protein XPA.","date":"2003","source":"Chemical research in toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/12588196","citation_count":67,"is_preprint":false},{"pmid":"9180928","id":"PMC_9180928","title":"Spontaneous liver tumors and benzo[a]pyrene-induced lymphomas in XPA-deficient mice.","date":"1997","source":"Molecular carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/9180928","citation_count":66,"is_preprint":false},{"pmid":"18990233","id":"PMC_18990233","title":"Alterations in candidate genes PHF2, FANCC, PTCH1 and XPA at chromosomal 9q22.3 region: pathological significance in early- and late-onset breast carcinoma.","date":"2008","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/18990233","citation_count":66,"is_preprint":false},{"pmid":"9450477","id":"PMC_9450477","title":"Induction of DNA adducts and mutations in spleen, liver and lung of XPA-deficient/lacZ transgenic mice after oral treatment with benzo[a]pyrene: correlation with tumour development.","date":"1997","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/9450477","citation_count":60,"is_preprint":false},{"pmid":"16513681","id":"PMC_16513681","title":"XPA, haplotypes, and risk of basal and squamous cell carcinoma.","date":"2006","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/16513681","citation_count":59,"is_preprint":false},{"pmid":"24953096","id":"PMC_24953096","title":"Poly(ADP-ribose)-mediated interplay of XPA and PARP1 leads to reciprocal regulation of protein function.","date":"2014","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/24953096","citation_count":59,"is_preprint":false},{"pmid":"23152873","id":"PMC_23152873","title":"Nucleotide excision repair is associated with the replisome and its efficiency depends on a direct interaction between XPA and PCNA.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23152873","citation_count":58,"is_preprint":false},{"pmid":"15914671","id":"PMC_15914671","title":"Human XPC-hHR23B interacts with XPA-RPA in the recognition of triplex-directed psoralen DNA interstrand crosslinks.","date":"2005","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/15914671","citation_count":57,"is_preprint":false},{"pmid":"12390028","id":"PMC_12390028","title":"Dimerization of human XPA and formation of XPA2-RPA protein complex.","date":"2002","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12390028","citation_count":56,"is_preprint":false},{"pmid":"23178497","id":"PMC_23178497","title":"Coordinated regulation of XPA stability by ATR and HERC2 during nucleotide excision repair.","date":"2012","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/23178497","citation_count":56,"is_preprint":false},{"pmid":"7598728","id":"PMC_7598728","title":"Enhancement of damage-specific DNA binding of XPA by interaction with the ERCC1 DNA repair protein.","date":"1995","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/7598728","citation_count":56,"is_preprint":false},{"pmid":"22467238","id":"PMC_22467238","title":"HIF1α regulated expression of XPA contributes to cisplatin resistance in lung cancer.","date":"2012","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/22467238","citation_count":55,"is_preprint":false},{"pmid":"32235701","id":"PMC_32235701","title":"XPA: DNA Repair Protein of Significant Clinical Importance.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32235701","citation_count":54,"is_preprint":false},{"pmid":"8105686","id":"PMC_8105686","title":"High prevalence of the point mutation in exon 6 of the xeroderma pigmentosum group A-complementing (XPAC) gene in xeroderma pigmentosum group A patients in Tunisia.","date":"1993","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8105686","citation_count":52,"is_preprint":false},{"pmid":"11841234","id":"PMC_11841234","title":"Strand-specific binding of RPA and XPA to damaged duplex DNA.","date":"2002","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11841234","citation_count":52,"is_preprint":false},{"pmid":"23807173","id":"PMC_23807173","title":"Association between ERCC1 and XPA expression and polymorphisms and the response to cisplatin in testicular germ cell tumours.","date":"2013","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/23807173","citation_count":51,"is_preprint":false},{"pmid":"10828957","id":"PMC_10828957","title":"RPA stabilizes the XPA-damaged DNA complex through protein-protein interaction.","date":"2000","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10828957","citation_count":50,"is_preprint":false},{"pmid":"11258902","id":"PMC_11258902","title":"Binding of XPA and RPA to damaged DNA investigated by fluorescence anisotropy.","date":"2001","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11258902","citation_count":50,"is_preprint":false},{"pmid":"11058119","id":"PMC_11058119","title":"A novel cytoplasmic GTPase XAB1 interacts with DNA repair protein XPA.","date":"2000","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/11058119","citation_count":50,"is_preprint":false},{"pmid":"1918083","id":"PMC_1918083","title":"Identification and characterization of xpac protein, the gene product of the human XPAC (xeroderma pigmentosum group A complementing) gene.","date":"1991","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/1918083","citation_count":48,"is_preprint":false},{"pmid":"1939167","id":"PMC_1939167","title":"xP1 and xP4. P-domain peptides expressed in Xenopus laevis stomach mucosa.","date":"1991","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/1939167","citation_count":48,"is_preprint":false},{"pmid":"15598786","id":"PMC_15598786","title":"Association between the risk for lung adenocarcinoma and a (-4) G-to-A polymorphism in the XPA gene.","date":"2004","source":"Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/15598786","citation_count":45,"is_preprint":false},{"pmid":"18053776","id":"PMC_18053776","title":"Nucleotide excision repair and the degradation of RNA pol II by the Caenorhabditis elegans XPA and Rsp5 orthologues, RAD-3 and WWP-1.","date":"2007","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/18053776","citation_count":44,"is_preprint":false},{"pmid":"11695546","id":"PMC_11695546","title":"DNA repair-deficient Xpa and Xpa/p53+/- knock-out mice: nature of the models.","date":"2001","source":"Toxicologic pathology","url":"https://pubmed.ncbi.nlm.nih.gov/11695546","citation_count":43,"is_preprint":false},{"pmid":"1339397","id":"PMC_1339397","title":"Molecular basis of group A xeroderma pigmentosum: a missense mutation and two deletions located in a zinc finger consensus sequence of the XPAC gene.","date":"1992","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/1339397","citation_count":43,"is_preprint":false},{"pmid":"9394039","id":"PMC_9394039","title":"Differential expression of the TFF-peptides xP1 and xP4 in the gastrointestinal tract of Xenopus laevis.","date":"1998","source":"Cell and tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/9394039","citation_count":42,"is_preprint":false},{"pmid":"31925419","id":"PMC_31925419","title":"A key interaction with RPA orients XPA in NER complexes.","date":"2020","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/31925419","citation_count":42,"is_preprint":false},{"pmid":"25847421","id":"PMC_25847421","title":"TP53 mutations induced by BPDE in Xpa-WT and Xpa-Null human TP53 knock-in (Hupki) mouse embryo fibroblasts.","date":"2015","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/25847421","citation_count":39,"is_preprint":false},{"pmid":"11695547","id":"PMC_11695547","title":"Xpa and Xpa/p53+/- knockout mice: overview of available data.","date":"2001","source":"Toxicologic pathology","url":"https://pubmed.ncbi.nlm.nih.gov/11695547","citation_count":38,"is_preprint":false},{"pmid":"26865925","id":"PMC_26865925","title":"Role of the XPA protein in the NER pathway: A perspective on the function of structural disorder in macromolecular assembly.","date":"2015","source":"Computational and structural biotechnology journal","url":"https://pubmed.ncbi.nlm.nih.gov/26865925","citation_count":38,"is_preprint":false},{"pmid":"7614689","id":"PMC_7614689","title":"Expression of a transfected DNA repair gene (XPA) in xeroderma pigmentosum group A cells restores normal DNA repair and mutagenesis of UV-treated plasmids.","date":"1995","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/7614689","citation_count":38,"is_preprint":false},{"pmid":"25056193","id":"PMC_25056193","title":"Redefining the DNA-binding domain of human XPA.","date":"2014","source":"Journal of the American Chemical Society","url":"https://pubmed.ncbi.nlm.nih.gov/25056193","citation_count":36,"is_preprint":false},{"pmid":"12243352","id":"PMC_12243352","title":"The Caenorhabditis elegans XPA homolog of human XPA.","date":"2002","source":"Molecules and cells","url":"https://pubmed.ncbi.nlm.nih.gov/12243352","citation_count":36,"is_preprint":false},{"pmid":"10838141","id":"PMC_10838141","title":"Mutagenesis and carcinogenesis in nucleotide excision repair-deficient XPA knock out mice.","date":"2000","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/10838141","citation_count":35,"is_preprint":false},{"pmid":"19197159","id":"PMC_19197159","title":"UV-dependent interaction between Cep164 and XPA mediates localization of Cep164 at sites of DNA damage and UV sensitivity.","date":"2009","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/19197159","citation_count":34,"is_preprint":false},{"pmid":"25368379","id":"PMC_25368379","title":"The RASSF1A tumor suppressor regulates XPA-mediated DNA repair.","date":"2014","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/25368379","citation_count":33,"is_preprint":false},{"pmid":"16792756","id":"PMC_16792756","title":"A novel mutation in the XPA gene associated with unusually mild clinical features in a patient who developed a spindle cell melanoma.","date":"2006","source":"The British journal of dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/16792756","citation_count":32,"is_preprint":false},{"pmid":"15882075","id":"PMC_15882075","title":"Cooperative interaction of human XPA stabilizes and enhances specific binding of XPA to DNA damage.","date":"2005","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15882075","citation_count":31,"is_preprint":false},{"pmid":"19056823","id":"PMC_19056823","title":"Physical and functional interaction between DDB and XPA in nucleotide excision repair.","date":"2008","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/19056823","citation_count":31,"is_preprint":false},{"pmid":"12082027","id":"PMC_12082027","title":"Low amounts of the DNA repair XPA protein are sufficient to recover UV-resistance.","date":"2002","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/12082027","citation_count":31,"is_preprint":false},{"pmid":"11906820","id":"PMC_11906820","title":"The novel human HUEL (C4orf1) protein shares homology with the DNA-binding domain of the XPA DNA repair protein and displays nuclear translocation in a cell cycle-dependent manner.","date":"2002","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/11906820","citation_count":31,"is_preprint":false},{"pmid":"15661658","id":"PMC_15661658","title":"Severe growth retardation and short life span of double-mutant mice lacking Xpa and exon 15 of Xpg.","date":"2005","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/15661658","citation_count":31,"is_preprint":false},{"pmid":"8294029","id":"PMC_8294029","title":"Genomic characterization of the human DNA excision repair-controlling gene XPAC.","date":"1993","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/8294029","citation_count":30,"is_preprint":false},{"pmid":"35969784","id":"PMC_35969784","title":"Two interaction surfaces between XPA and RPA organize the preincision complex in nucleotide excision repair.","date":"2022","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/35969784","citation_count":30,"is_preprint":false},{"pmid":"28528167","id":"PMC_28528167","title":"CXCL1 Inhibition Regulates UVB-Induced Skin Inflammation and Tumorigenesis in Xpa-Deficient Mice.","date":"2017","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/28528167","citation_count":30,"is_preprint":false},{"pmid":"8464385","id":"PMC_8464385","title":"A single-site mutation in the XPAC gene alters photoproduct recognition.","date":"1993","source":"Mutagenesis","url":"https://pubmed.ncbi.nlm.nih.gov/8464385","citation_count":29,"is_preprint":false},{"pmid":"31906898","id":"PMC_31906898","title":"Increased levels of XPA might be the basis of cisplatin resistance in germ cell tumours.","date":"2020","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/31906898","citation_count":29,"is_preprint":false},{"pmid":"20509621","id":"PMC_20509621","title":"Antimony impairs nucleotide excision repair: XPA and XPE as potential molecular targets.","date":"2010","source":"Chemical research in toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/20509621","citation_count":29,"is_preprint":false},{"pmid":"16510579","id":"PMC_16510579","title":"Induction of nevi and skin tumors in Ink4a/Arf Xpa knockout mice by neonatal, intermittent, or chronic UVB exposures.","date":"2006","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/16510579","citation_count":29,"is_preprint":false},{"pmid":"1764072","id":"PMC_1764072","title":"Molecular cloning of human XPAC gene homologs from chicken, Xenopus laevis and Drosophila melanogaster.","date":"1991","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/1764072","citation_count":28,"is_preprint":false},{"pmid":"21999933","id":"PMC_21999933","title":"Both XPA and DNA polymerase eta are necessary for the repair of doxorubicin-induced DNA lesions.","date":"2011","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/21999933","citation_count":28,"is_preprint":false},{"pmid":"30327428","id":"PMC_30327428","title":"Sirtuin 1-mediated deacetylation of XPA DNA repair protein enhances its interaction with ATR protein and promotes cAMP-induced DNA repair of UV damage.","date":"2018","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30327428","citation_count":28,"is_preprint":false},{"pmid":"12907715","id":"PMC_12907715","title":"NMR study on the interaction between RPA and DNA decamer containing cis-syn cyclobutane pyrimidine dimer in the presence of XPA: implication for damage verification and strand-specific dual incision in nucleotide excision repair.","date":"2003","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/12907715","citation_count":28,"is_preprint":false},{"pmid":"19181108","id":"PMC_19181108","title":"XPA gene, its product and biological roles.","date":"2008","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/19181108","citation_count":27,"is_preprint":false},{"pmid":"10946233","id":"PMC_10946233","title":"Three-dimensional structural views of damaged-DNA recognition: T4 endonuclease V, E. coli Vsr protein, and human nucleotide excision repair factor XPA.","date":"2000","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/10946233","citation_count":27,"is_preprint":false},{"pmid":"30386247","id":"PMC_30386247","title":"XPA, XPC, and XPD Modulate Sensitivity in Gastric Cisplatin Resistance Cancer Cells.","date":"2018","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/30386247","citation_count":27,"is_preprint":false},{"pmid":"10833384","id":"PMC_10833384","title":"Overexpression and purification of human XPA using a baculovirus expression system.","date":"2000","source":"Protein expression and purification","url":"https://pubmed.ncbi.nlm.nih.gov/10833384","citation_count":26,"is_preprint":false},{"pmid":"12531021","id":"PMC_12531021","title":"Additive roles of XPA and MSH2 genes in UVB-induced skin tumorigenesis in mice.","date":"2002","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/12531021","citation_count":26,"is_preprint":false},{"pmid":"20431719","id":"PMC_20431719","title":"Pterygium and genetic polymorphisms of the DNA repair enzymes XRCC1, XPA, and XPD.","date":"2010","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/20431719","citation_count":25,"is_preprint":false},{"pmid":"28552776","id":"PMC_28552776","title":"Differential sensitivities of cellular XPA and PARP-1 to arsenite inhibition and zinc rescue.","date":"2017","source":"Toxicology and applied pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/28552776","citation_count":24,"is_preprint":false},{"pmid":"20410141","id":"PMC_20410141","title":"XPA impacts formation but not proteasome-sensitive repair of DNA-protein cross-links induced by chromate.","date":"2010","source":"Mutagenesis","url":"https://pubmed.ncbi.nlm.nih.gov/20410141","citation_count":24,"is_preprint":false},{"pmid":"18774935","id":"PMC_18774935","title":"Interaction of nucleotide excision repair factors XPC-HR23B, XPA, and RPA with damaged DNA.","date":"2008","source":"Biochemistry. Biokhimiia","url":"https://pubmed.ncbi.nlm.nih.gov/18774935","citation_count":24,"is_preprint":false},{"pmid":"18240296","id":"PMC_18240296","title":"Elevation of XPA protein level in testis tumor cells without increasing resistance to cisplatin or UV radiation.","date":"2008","source":"Molecular carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/18240296","citation_count":24,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":47218,"output_tokens":9575,"usd":0.14264,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":19972,"output_tokens":6174,"usd":0.127105,"stage2_stop_reason":"end_turn"},"total_usd":0.269745,"stage1_batch_id":"msgbatch_01UT1AahFPCAyn2uVweS7A9z","stage2_batch_id":"msgbatch_01HuKWtKNT4Pqj1bc8eEP5RV","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1994,\n      \"finding\": \"XPA protein is a zinc metalloprotein that binds preferentially to UV-, cisplatin-, and OsO4-damaged DNA; a cysteine residue (Cys-103) in the C4-type zinc finger motif is indispensable for normal protein conformation and DNA-binding/NER activity, as shown by site-directed mutagenesis.\",\n      \"method\": \"Bacterially expressed recombinant XPA protein; nitrocellulose filter-binding assay for damaged DNA; atomic absorption and UV-CD spectroscopy; site-directed mutagenesis of Cys-103; microinjection complementation assay\",\n      \"journal\": \"Mutation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution with mutagenesis plus functional complementation, replicated across multiple methods in a single study\",\n      \"pmids\": [\"7526200\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"XPA and ERCC1 specifically interact both in vivo (yeast two-hybrid) and in vitro (recombinant proteins); the interaction domains were initially mapped, suggesting XPA recruits the ERCC1-containing incision complex to damaged DNA.\",\n      \"method\": \"Yeast two-hybrid system; in vitro binding with recombinant proteins; domain mapping\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal in vivo and in vitro methods, replicated in multiple subsequent studies\",\n      \"pmids\": [\"8197174\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"XPA forms a ternary complex with ERCC1 and ERCC4(XPF) heterodimer; an XPA affinity column depletes excision activity from HeLa extracts, which is restored by the XPA-bound fraction; the bound fraction complements ERCC1, ERCC4/XPF, and XPA-deficient extracts.\",\n      \"method\": \"XPA affinity column chromatography; in vitro complementation assay with cell-free extracts from repair-deficient cell lines\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstitution with affinity chromatography and functional complementation; independently replicated\",\n      \"pmids\": [\"8197175\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"XPA interacts with both the 70-kDa and 34-kDa subunits of RPA at distinct sites; the RPA70-interaction domain maps to XPA residues 153–176, and deletion mutants within this region are deficient in RPA binding and highly defective in NER both in vitro and in vivo; the XPA–RPA complex has greater affinity for damaged DNA than XPA alone.\",\n      \"method\": \"In vitro binding assays; yeast two-hybrid; deletion mutagenesis; in vitro NER assay; in vivo complementation of XPA-deficient cells\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — mutagenesis combined with in vitro and in vivo functional assays; replicated across methods\",\n      \"pmids\": [\"7565690\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"XPA mutations that delete the G motif (Gly-72–Phe-75) or E motif (Glu-78–Glu-84) prevent association with ERCC1 and fail to complement XPA-deficient extracts in NER; the delta-G mutant acts as a dominant negative in wild-type extracts, indicating that the XPA–ERCC1 interaction is required for NER.\",\n      \"method\": \"Site-specific mutagenesis; in vitro ERCC1-binding assay; in vitro DNA repair synthesis assay; in vivo complementation\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — mutagenesis with multiple functional readouts; dominant-negative result confirms mechanistic requirement\",\n      \"pmids\": [\"7891694\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"XPA interacts with the 34-kDa subunit of RPA, as identified by yeast two-hybrid; the RPA complex (70/34/11 kDa) associates with XPA, suggesting cooperation in early NER steps.\",\n      \"method\": \"Yeast two-hybrid; co-association with RPA complex\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — yeast two-hybrid plus biochemical co-association; single lab but corroborated by concurrent studies\",\n      \"pmids\": [\"7876167\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Enhancement of XPA's damaged-DNA binding by ERCC1; XPA–ERCC1 interaction requires a stretch of consecutive glutamic acid residues in XPA; ERCC1 does not enhance binding when the truncated XPA-MF122 (lacking the protein–protein interaction region) is used.\",\n      \"method\": \"In vitro binding assay; yeast two-hybrid; electrophoretic mobility shift assay with truncation mutants\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct binding and truncation analysis in a single lab with two orthogonal methods\",\n      \"pmids\": [\"7598728\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"The damaged-DNA binding domain of XPA is contained within residues 98–219 (MF122 fragment), which includes a C4-type zinc finger motif and has helix-rich secondary structure; this domain is sufficient for preferential binding to UV- or cisplatin-damaged DNA.\",\n      \"method\": \"Truncation analysis; nitrocellulose filter-binding assay; circular dichroism spectroscopy\",\n      \"journal\": \"Mutation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — domain mapping with biophysical structural confirmation and functional binding assay\",\n      \"pmids\": [\"8538652\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"RPA and ERCC1 bind XPA at non-overlapping regions; a ternary RPA–XPA–ERCC1 complex forms in vitro; sequential binding occurs with RPA (KD ~19 nM) binding before ERCC1 (KD ~250 nM) based on surface plasmon resonance.\",\n      \"method\": \"In vitro binding/truncation assays; surface plasmon resonance biosensor; detection of ternary complex\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — SPR kinetics plus domain mapping; single lab but rigorous biophysical methods\",\n      \"pmids\": [\"8972858\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"TFIIH has some affinity for DNA but unlike XPA does not prefer UV-damaged DNA; TFIIH binds to XPA·DNA complexes in a UV damage-dependent manner via direct protein–protein interaction, suggesting XPA recruits TFIIH to damage sites.\",\n      \"method\": \"Filter binding assays; pull-down experiments; TFIIH interaction with XPA·DNA complexes\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pull-down and filter binding with both undamaged and UV-damaged DNA substrates; single lab\",\n      \"pmids\": [\"9287294\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"RPA32 C-terminal globular domain interacts with XPA (and UNG2, RAD52) through a common structural surface; NMR structures of RPA32C free and in complex with UNG2 define the shared binding interface, establishing a structural basis for XPA recruitment by RPA.\",\n      \"method\": \"NMR structure determination; binding assays with XPA, UNG2, RAD52\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — NMR structure with functional binding validation across multiple repair proteins\",\n      \"pmids\": [\"11081631\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"XPA interacts with the novel cytoplasmic GTPase XAB1; XAB1 binds the N-terminal region of XPA (residues 30–34 required for nuclear localization); deletion of residues 30–34 abolishes XAB1 interaction, implicating XAB1 in nuclear import of XPA.\",\n      \"method\": \"Yeast two-hybrid screen of HeLa cDNA library; deletion mapping; immunofluorescence\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — yeast two-hybrid plus deletion analysis and localization data; single lab\",\n      \"pmids\": [\"11058119\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"RPA stabilizes the XPA–damaged DNA complex through protein–protein interaction; wild-type RPA enhances XPA binding to (6-4) photoproduct-containing DNA, whereas a mutant RPA (p34Δ33C) defective in XPA interaction fails to stabilize this complex.\",\n      \"method\": \"Surface plasmon resonance analysis; mutant RPA lacking XPA interaction domain\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — SPR with specific domain-disrupting mutant; rigorous biophysical approach\",\n      \"pmids\": [\"10828957\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"XPA–RPA complex acts as a double-check sensor: XPA binds rigidly bent duplexes (backbone distortion) via indirect readout, while RPA recognizes single-stranded regions (base pair disruption); together they simultaneously detect backbone and base pair distortion, supporting a damage-verification/assembly role rather than direct lesion recognition.\",\n      \"method\": \"DNA binding assays with substrates containing mispaired bases, non-hybridizing analogues, and artificially bent duplexes; electrophoretic mobility shift assays\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — systematic substrate analysis with engineered DNA structures; single lab, multiple orthogonal substrates\",\n      \"pmids\": [\"11432842\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"XPA forms a homodimer (XPA2) in solution under normal conditions; the dimer, not the monomer, forms the complex with RPA; XPA contains post-translational modifications as indicated by mass spectrometry.\",\n      \"method\": \"Native gel filtration chromatography; native PFO-PAGE; fluorescence spectroscopy; mass spectrometry; baculovirus-expressed protein\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple biophysical methods in a single lab; single study\",\n      \"pmids\": [\"12390028\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"XPA contacts both the damaged and undamaged strands of a damaged duplex DNA, while RPA binds preferentially to the undamaged strand; demonstrated using photoreactive base analogues in specific substrates for site-specific crosslinking.\",\n      \"method\": \"Site-specific photocrosslinking with photoreactive base analogues; strand-specific analysis\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — site-specific crosslinking with chemically defined substrates; single lab\",\n      \"pmids\": [\"11841234\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"In the presence of XPA, RPA binds specifically to the undamaged strand of CPD-containing duplex DNA, whereas without XPA both strands are bound non-specifically; this strand-specific interaction is relevant for guiding XPG/XPF nucleases to the correct cleavage sites.\",\n      \"method\": \"NMR spectroscopy with RPA-A and RPA-AB domains; CPD-containing duplex DNA substrates\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — NMR structural analysis with defined damaged substrates; single lab\",\n      \"pmids\": [\"12907715\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"XPA binds damaged DNA cooperatively: at lower concentrations as a monomer, at higher concentrations as a dimer; the dimer is the dominant form for efficient damage binding, with a Hill coefficient of ~1.9 and stepwise binding constants determined; RPA presence does not substantially enhance overall binding efficiency.\",\n      \"method\": \"Gel mobility shift assay; gel filtration chromatography; UV-crosslinking; fluorescence spectroscopy; competitive binding assay\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal biochemical methods; single lab\",\n      \"pmids\": [\"15882075\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Crystal structure of ERCC1 bound to an XPA peptide shows that only a small region of XPA interacts with ERCC1 with submicromolar affinity; this XPA peptide is a potent inhibitor of NER activity in a cell-free excision assay; the structure defines the XPA–ERCC1 binding interface.\",\n      \"method\": \"Crystal structure determination; fluorescence anisotropy binding assay; cell-free NER excision assay with peptide inhibitor\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure plus functional inhibition assay; rigorous structural and biochemical validation\",\n      \"pmids\": [\"17948053\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"DDB directly interacts with XPA primarily through the DDB2 subunit; XPA residues 185–226 are important for this interaction; the point mutation R207G in XPA disrupts DDB interaction in vitro and in vivo, abrogates DDB-stimulated CPD excision in a reconstituted system, and reduces XPA recruitment to damage sites in cells.\",\n      \"method\": \"In vitro binding assays; co-immunoprecipitation; site-directed mutagenesis (R207G); cell-free NER excision assay; in vivo repair assays\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — mutagenesis with multiple in vitro and in vivo functional readouts in a single rigorous study\",\n      \"pmids\": [\"19056823\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"SIRT1 interacts with XPA, and this interaction is enhanced after UV irradiation; SIRT1 deacetylates XPA at Lys-63 and Lys-67 both in vitro and in cells; hyperacetylated XPA (K63/67Q mimetic) is NER-defective and shows increased UV sensitivity; SIRT1-mediated deacetylation of XPA enhances XPA–RPA32 interaction.\",\n      \"method\": \"Co-immunoprecipitation; in vitro deacetylation assay; XPA K63Q/K67Q acetylation-mimetic mutants; UV survival assay; in vivo NER assay\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro enzymatic assay plus mutagenesis with multiple functional readouts in cells\",\n      \"pmids\": [\"20670893\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"XPA protein undergoes circadian oscillation in mouse liver (but not testis) regulated at the transcriptional level by core circadian clock proteins including cryptochrome, and at the post-translational level by HERC2 ubiquitin ligase; consequently, cisplatin-adduct repair in liver extracts shows a circadian pattern.\",\n      \"method\": \"Immunoblotting of mouse liver/testis extracts at circadian time points; in vitro excision repair assays; analysis of cryptochrome and HERC2 role\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo biochemistry in mouse tissues plus functional repair assays with circadian regulation demonstrated\",\n      \"pmids\": [\"20304803\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"XPA is a rate-limiting factor for NER in all human cell lines tested; its level is regulated post-translationally by the HECT-domain E3 ubiquitin ligase HERC2; DNA damage promotes tight association of XPA with chromatin and dissociation from HERC2, thereby inhibiting XPA ubiquitination and degradation; XPA is acetylated but in mouse liver only a small fraction is acetylated.\",\n      \"method\": \"siRNA knockdown of HERC2 and XPA; Tet-regulatable XPA expression; co-immunoprecipitation; chromatin fractionation; repair assays\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods including knockdown, regulated expression, co-IP, and functional repair assays\",\n      \"pmids\": [\"21193487\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"ATR phosphorylates XPA at Ser-196, enhancing XPA stability by inhibiting HERC2-mediated ubiquitination and degradation; S196A (phosphodeficient) mutant shows persistent HERC2 association and enhanced ubiquitination; S196D (phosphomimetic) shows reduced HERC2 binding and delayed degradation; ATR-mediated phosphorylation also enhances chromatin retention of XPA and its interaction with binding partners after DNA damage.\",\n      \"method\": \"Site-directed mutagenesis (S196A, S196D); co-immunoprecipitation; ubiquitination assay; chromatin fractionation; XPA-deficient cell complementation\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — phosphomimetic and phosphodeficient mutagenesis with multiple functional readouts; single rigorous study\",\n      \"pmids\": [\"23178497\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"XPA contains a functional PCNA-interacting motif (APIM); XPA colocalizes with PCNA in replication foci and is loaded on newly synthesized DNA in undamaged cells; XPA-deficient cells complemented with APIM-mutant XPA show increased UV sensitivity, reduced CPD and (6-4) photoproduct repair, and increased S-phase arrest; TFIIH subunit XPD and XPF are also loaded on DNA together with XPA.\",\n      \"method\": \"Live cell imaging; PCNA co-localization; XPA APIM mutagenesis; UV survival and repair assays in XPA-/- cells; chromatin loading assays\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mutagenesis combined with functional repair and localization assays; single lab\",\n      \"pmids\": [\"23152873\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"XPA binds poly(ADP-ribose) (PAR) non-covalently via specific basic amino acids in a conserved PAR-binding motif that overlaps the DDB2 and TFIIH interaction domains; XPA–PAR interaction lowers XPA's DNA-binding affinity; XPA strongly stimulates PARP1 enzymatic activity; PARP inhibition alters XPA-GFP recruitment to laser-induced DNA damage sites.\",\n      \"method\": \"PAR-binding assays with XPA mutants; biochemical PARP1 activity assay; live-cell microirradiation with XPA-GFP; co-immunoprecipitation\",\n      \"journal\": \"The FEBS journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (biochemical, live imaging) in single lab\",\n      \"pmids\": [\"24953096\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Defective mitophagy in XPA-deficient cells is caused by PARP-1 hyperactivation leading to decreased NAD+–SIRT1–PGC-1α axis activity; PARP-1 inhibition or NAD+ precursor supplementation rescues mitochondrial defects and lifespan in xpa-1 nematodes; this nuclear-mitochondrial crosstalk pathway is absent in XPC (NER-deficient without neurodegeneration).\",\n      \"method\": \"In silico analysis; in vivo XPA-deficient cells and xpa-1 C. elegans; PARP inhibitor treatment; NAD+ supplementation; mitochondrial membrane potential assays\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic and pharmacological rescue experiments in multiple systems; high citation independent replication evidence\",\n      \"pmids\": [\"24813611\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Redefined DNA-binding domain of XPA extends to residue 239 (XPA 98–239), not residue 219 as previously reported; XPA(98–239) binds Y-shaped ssDNA/dsDNA junction with the same affinity as full-length XPA; the construct undergoes a conformational change upon DNA binding.\",\n      \"method\": \"Fluorescence anisotropy DNA-binding assay; 2D 15N-1H NMR; C-terminal extension series of XPA constructs\",\n      \"journal\": \"Journal of the American Chemical Society\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — NMR plus quantitative binding assay with multiple constructs; redefines prior domain boundaries\",\n      \"pmids\": [\"25056193\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"XPA activates unwinding of normal DNA by TFIIH Core7 but inhibits Core7 helicase activity in the presence of bulky lesions; bulky lesions inhibit XPB and XPD ATPase/helicase activities to promote NER; XPA, XPC, and TFIIH constitute a tripartite lesion verification mechanism.\",\n      \"method\": \"Reconstitution of human ten-subunit TFIIH and Core7; ATPase and helicase activity assays with defined substrates; NER assays with defined lesions\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — full biochemical reconstitution with purified homogeneous TFIIH; in vitro enzymatic assays with rigorous controls\",\n      \"pmids\": [\"26384665\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"SIRT1 deacetylates XPA at Lys-63, Lys-67, and Lys-215 to promote XPA interactions with ATR; acetylation mimetics at these residues blunt UV-dependent ATR–XPA interaction even in the presence of cAMP; ATR-mediated phosphorylation of XPA at Ser-196 enhances cAMP-mediated NER and is promoted by SIRT1-mediated deacetylation.\",\n      \"method\": \"Co-immunoprecipitation; acetylation-mimetic and phosphomimetic/deficient mutants; UV-damage repair assays; cAMP signaling manipulation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mutagenesis with functional repair readouts; single lab, extends prior SIRT1/XPA findings\",\n      \"pmids\": [\"30327428\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Two distinct interaction surfaces between XPA and RPA organize the NER preincision complex: (1) XPA N-terminal disordered domain with RPA32C, and (2) XPA DNA-binding domain with RPA70AB; mutations disrupting either site reduce NER activity, and combining both mutations additively inhibits NER; integrative structural modeling places the NER bubble in a U-shape with the two ssDNA/dsDNA junctions in proximity.\",\n      \"method\": \"NMR mapping of binding interfaces; X-ray scattering; comprehensive docking and refinement; XPA mutations inhibiting RPA70AB interaction; biochemical and cellular NER assays\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — NMR plus SAXS plus mutagenesis plus functional NER assays; multiple orthogonal methods\",\n      \"pmids\": [\"31925419\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Both XPA–RPA interaction sites (XPA-N/RPA32C and XPA-DBD/RPA70AB) are functionally required for NER; mutations in either site reduce NER in biochemical and cellular systems; combining mutations in both sites is additive; the XPA-N–RPA32C contact is important for initial XPA association with NER complexes, while XPA-DBD–RPA70AB contact organizes the complex for dual incision; the NER bubble assumes a U-shape geometry.\",\n      \"method\": \"Site-directed mutagenesis; in vitro NER biochemical assays; cell-based NER assays; integrative structural modeling with SAXS and NMR data\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — mutagenesis with biochemical reconstitution and cellular functional assays; multiple orthogonal methods\",\n      \"pmids\": [\"35969784\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Cryo-EM structures reveal that XPA binds between XPB and XPD helicases of TFIIH Core7 and kinks the DNA duplex; this shifts XPC and the DNA lesion by nearly a helical turn relative to Core7, positioning the lesion outside Core7 for verification; XPB and XPD track the lesion-containing strand in opposite directions, pushing and pulling it into XPD for verification.\",\n      \"method\": \"Cryo-EM structure determination of human XPC–TFIIH–XPA–DNA complexes\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — cryo-EM structures directly show XPA positioning within NER complexes at high resolution\",\n      \"pmids\": [\"37076618\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"UV-induced ATR signaling (ATRIP translocation to UV damage sites, Chk1 phosphorylation, RPA phosphorylation and chromatin binding) is compromised in XPA-deficient human cells during S phase, but not in XPC-, CSB-, XPF-, or XPG-deficient cells; the lesion-recognition function of XPA (not damage processing) is sufficient for ATR-mediated S-phase checkpoint activation.\",\n      \"method\": \"Immunofluorescence for ATRIP translocation; western blotting for Chk1 and RPA phosphorylation; chromatin fractionation in NER-factor-deficient human cell lines\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — epistasis analysis across multiple NER-deficient cell lines with defined molecular readouts; single lab\",\n      \"pmids\": [\"16675950\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Cep164 is recruited to CPD sites in a UV-dependent manner requiring XPA; UV irradiation enhances the physical interaction between Cep164 and XPA; Cep164 binds XPA residues 4–97; XPA(Δ10-88) mutant cells show aberrant Cep164/CPD co-localization and impaired UV-induced CHK1 phosphorylation.\",\n      \"method\": \"Co-immunoprecipitation; chromatin immunoprecipitation; immunofluorescence co-localization; XPA deletion mutants; CHK1 phosphorylation assay\",\n      \"journal\": \"Cell cycle (Georgetown, Tex.)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP plus deletion mapping plus functional checkpoint readout; single lab\",\n      \"pmids\": [\"19197159\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"RASSF1A forms a DNA damage-regulated complex with XPA and is required for full XPA repair activity; RASSF1A-deficient cells have impaired DNA repair; a cancer-associated RASSF1A SNP shows differential XPA binding and inhibits repair; RASSF1A and its SNP variant differentially regulate XPA acetylation and modulate the XPA–RPA70 complex.\",\n      \"method\": \"Co-immunoprecipitation; DNA repair assays in RASSF1A-deficient cells; SNP variant binding analysis; acetylation assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP with functional repair readout and SNP analysis; single lab\",\n      \"pmids\": [\"25368379\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Nickel(II), Cd(II), Co(II), and Cu(II) reduce XPA's DNA-binding ability; simultaneous treatment with Zn(II) largely prevents inhibition by Cd(II), Co(II), and Ni(II); Ni(II) does not form the same tetrahedral zinc finger complex as Zn(II).\",\n      \"method\": \"Nitrocellulose filter-binding assay for XPA activity; Zn(II) competition experiments\",\n      \"journal\": \"Carcinogenesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct in vitro activity assay with metal competition; single lab\",\n      \"pmids\": [\"11062174\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Ni(II) substitutes Zn(II) in the XPA zinc finger peptide (XPAzf) forming a square planar complex; this abolishes the normal tetrahedral zinc finger structure; Ni(II)-substituted XPAzf is highly susceptible to oxidative damage by H2O2; binding constants for Zn(II)/Ni(II) differ by ~800–2300-fold.\",\n      \"method\": \"Fluorescence spectroscopy; UV-vis and CD spectroscopy; HPLC oxidative damage analysis; synthetic XPAzf peptide\",\n      \"journal\": \"Chemical research in toxicology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro biophysical characterization with synthetic zinc finger peptide; single lab, rigorous spectroscopic methods\",\n      \"pmids\": [\"12588196\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"XPA protein (xpac) is localized in the nucleus of human cells; two forms (~40 and ~38 kDa) are detected; reduced or absent protein in XP group A cells correlates with repair defect severity; protein level does not increase after UV irradiation.\",\n      \"method\": \"Antibody against recombinant xpac protein; SDS-PAGE/immunoblotting; indirect immunofluorescence\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct protein detection with specific antibody in normal and XP cells; single lab\",\n      \"pmids\": [\"1918083\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Full-length Xenopus XPA (xXPA) contains ordered internal core (residues ~Q85–I179) and disordered N- and C-terminal regions; mass spectrometry confirms no post-translational modifications in this species; xXPA binds cisplatin-modified ± mismatch DNA with at least 10-fold higher affinity than unmodified DNA.\",\n      \"method\": \"Time-resolved trypsin proteolysis; ESI-FTICR mass spectrometry; gel filtration chromatography; PONDR disorder prediction\",\n      \"journal\": \"Protein science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — mass spectrometry with proteolysis; rigorous structural characterization of Xenopus XPA; single lab\",\n      \"pmids\": [\"11420437\", \"11344324\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"DDB stimulates in vitro excision of CPDs (but not 6-4 photoproducts) in a reconstituted NER system; DDB elevates XPA binding to damaged DNA and forms a complex with damaged DNA together with XPA or XPA+RPA; the stimulation requires both XPA and RPA.\",\n      \"method\": \"In vitro NER excision assay; electrophoretic mobility shift assay; DNase I protection assay; addition of recombinant proteins to cell-free extracts\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reconstituted in vitro system with multiple protein combinations and lesion-specific assays; single lab\",\n      \"pmids\": [\"11278856\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"XPA functions as a central scaffold in the nucleotide excision repair (NER) pre-incision complex: it is a zinc metalloprotein with a C4-type zinc finger domain that binds preferentially to structurally distorted/damaged DNA via indirect readout of DNA backbone bending; it recruits the ERCC1–XPF endonuclease through a specific interaction with ERCC1 (mediated by XPA's G and E motifs), recruits TFIIH through direct protein–protein contact, and organizes the complex with RPA through two distinct interaction surfaces (XPA N-terminus/RPA32C and XPA DBD/RPA70AB); cryo-EM structures show XPA binding between XPB and XPD in TFIIH to kink the DNA and position the lesion for XPD-mediated verification; XPA's level and activity are regulated by HERC2-mediated ubiquitination/degradation (antagonized by ATR-mediated Ser-196 phosphorylation upon DNA damage), by SIRT1-mediated deacetylation at Lys-63/67/215 (which promotes ATR interaction and RPA32 binding), by PARP1-generated poly(ADP-ribose) (which lowers XPA's DNA affinity and is reciprocally stimulated by XPA), and by circadian-clock-driven transcription; additionally, XPA-deficient cells show defective mitophagy caused by PARP-1 hyperactivation and NAD+/SIRT1 reduction, revealing a nuclear-mitochondrial crosstalk role beyond direct DNA repair.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"XPA is the central scaffold of the nucleotide excision repair (NER) pre-incision complex, a zinc metalloprotein whose C4-type zinc finger (requiring Cys-103) is essential for proper folding and preferential binding to UV-, cisplatin-, and OsO4-damaged DNA [#0, #7]. Rather than directly reading the lesion, XPA recognizes structurally distorted/bent duplex DNA through indirect backbone readout, while its partner RPA recognizes the disrupted base-paired strand, forming a combined damage-verification sensor; XPA contacts both damaged and undamaged strands and RPA enforces strand-specific binding that orients the XPF and XPG nucleases [#13, #15, #16]. XPA assembles the incision machinery through defined protein contacts: its G and E motifs bind the ERCC1\\u2013XPF endonuclease (a contact required for NER and exploited as a peptide inhibitor) [#4, #18], it recruits TFIIH to damaged DNA in a damage-dependent manner [#9], and it organizes RPA through two distinct surfaces\\u2014an N-terminal disordered region engaging RPA32C and its DNA-binding domain engaging RPA70AB\\u2014that together fold the NER bubble into a U-shaped geometry [#30, #31]. Within TFIIH, XPA binds between the XPB and XPD helicases and kinks the DNA, repositioning the lesion outside Core7 so that XPB and XPD track the damaged strand in opposite directions to drive XPD-mediated lesion verification [#28, #32]. XPA is a rate-limiting NER factor whose abundance and activity are tightly regulated: HERC2 ubiquitin ligase targets XPA for degradation, antagonized by ATR-mediated Ser-196 phosphorylation upon damage, while SIRT1 deacetylates XPA at Lys-63/67/215 to promote ATR interaction and RPA32 binding, and circadian clock control drives oscillation of XPA-dependent repair [#20, #22, #23, #29, #21]. XPA also engages PARP1\\u2014binding poly(ADP-ribose), which lowers its DNA affinity, while reciprocally stimulating PARP1 activity\\u2014and beyond direct repair, XPA loss causes PARP-1 hyperactivation that depletes NAD+/SIRT1 and impairs mitophagy, revealing nuclear\\u2013mitochondrial crosstalk [#25, #26]. XPA further contributes to ATR-dependent S-phase checkpoint activation through its lesion-recognition function [#33].\",\n  \"teleology\": [\n    {\n      \"year\": 1991,\n      \"claim\": \"Established that XPA is a nuclear protein whose loss correlates with the severity of the repair defect in xeroderma pigmentosum group A cells, anchoring the gene to NER capacity.\",\n      \"evidence\": \"Specific antibody immunoblotting and immunofluorescence in normal and XP-A cells\",\n      \"pmids\": [\"1918083\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Did not define molecular activity\", \"Two protein forms not mechanistically explained\", \"No partner identified\"]\n    },\n    {\n      \"year\": 1994,\n      \"claim\": \"Answered how XPA recognizes damage and showed it is a metal-dependent damage sensor, defining the zinc finger as essential for conformation and DNA-binding/NER activity.\",\n      \"evidence\": \"Recombinant XPA filter-binding, spectroscopy, Cys-103 mutagenesis, and microinjection complementation\",\n      \"pmids\": [\"7526200\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of lesion discrimination not resolved\", \"Did not localize the minimal DNA-binding domain\"]\n    },\n    {\n      \"year\": 1994,\n      \"claim\": \"Identified XPA as the recruiter of the ERCC1\\u2013XPF incision complex, establishing a scaffold function beyond passive damage binding.\",\n      \"evidence\": \"Yeast two-hybrid, in vitro binding, affinity-column depletion/complementation with repair-deficient extracts\",\n      \"pmids\": [\"8197174\", \"8197175\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Interaction interface mapped only coarsely\", \"Order of complex assembly not defined\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Demonstrated that the XPA\\u2013ERCC1 contact through the G and E motifs is mechanistically required for NER, with a dominant-negative deletion confirming necessity.\",\n      \"evidence\": \"Site-specific mutagenesis with in vitro repair synthesis and in vivo complementation\",\n      \"pmids\": [\"7891694\", \"7598728\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Atomic interface not yet defined\", \"Functional consequence for nuclease positioning unknown at this stage\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Established XPA\\u2013RPA as a cooperative damage-binding pair, mapping the RPA70-interaction region and showing the complex binds damaged DNA more tightly than XPA alone.\",\n      \"evidence\": \"In vitro and yeast two-hybrid binding, deletion mutagenesis, in vitro and in vivo NER assays\",\n      \"pmids\": [\"7565690\", \"7876167\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of RPA contact not yet resolved\", \"Stoichiometry of the complex undefined\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Localized XPA's damaged-DNA binding to residues 98\\u2013219 and showed RPA and ERCC1 bind non-overlapping regions in a kinetically ordered ternary complex.\",\n      \"evidence\": \"Truncation analysis, CD spectroscopy, filter-binding, and surface plasmon resonance kinetics\",\n      \"pmids\": [\"8538652\", \"8972858\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Domain boundary later revised\", \"Order of assembly within the full complex still incomplete\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Showed XPA recruits TFIIH to damage sites, since TFIIH binds XPA\\u00b7DNA complexes in a UV-damage-dependent manner despite lacking intrinsic damage preference.\",\n      \"evidence\": \"Filter binding and pull-down with damaged and undamaged DNA substrates\",\n      \"pmids\": [\"9287294\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"TFIIH-contacting residues of XPA not mapped\", \"Single-lab evidence without structural detail\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Provided structural and mechanistic basis for RPA-mediated recruitment and stabilization of XPA, and linked XPA to nuclear import via the GTPase XAB1.\",\n      \"evidence\": \"NMR of RPA32C, SPR with XPA-interaction-defective RPA mutant, yeast two-hybrid screen with deletion mapping\",\n      \"pmids\": [\"11081631\", \"10828957\", \"11058119\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"XAB1 evidence is Medium-confidence single lab\", \"Full architecture of XPA\\u2013RPA on DNA still unresolved\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Defined XPA\\u2013RPA as a double-check sensor detecting backbone bending and base-pair disruption simultaneously, recasting XPA as a verification/assembly factor rather than a lesion reader.\",\n      \"evidence\": \"EMSA with mispaired, non-hybridizing, and artificially bent DNA substrates; DDB stimulation of CPD excision in reconstituted NER\",\n      \"pmids\": [\"11432842\", \"11278856\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Indirect-readout model based on engineered substrates\", \"DDB stimulation lesion-specificity mechanism unresolved\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Resolved the strand topology of XPA binding (both strands contacted) versus RPA (undamaged strand) and indicated XPA functions as a homodimer in the RPA complex.\",\n      \"evidence\": \"Site-specific photocrosslinking; native gel filtration, PFO-PAGE, and mass spectrometry\",\n      \"pmids\": [\"11841234\", \"12390028\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Oligomeric state in the full NER complex contested\", \"Functional role of dimerization not established in vivo\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Showed XPA confers strand specificity on RPA binding at CPD lesions, providing the basis for correct positioning of dual-incision nucleases.\",\n      \"evidence\": \"NMR with RPA-A/AB domains on CPD-containing duplex substrates\",\n      \"pmids\": [\"12907715\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct link to nuclease cleavage geometry inferred, not shown\", \"Single-lab structural study\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Defined the atomic XPA\\u2013ERCC1 interface and validated its functional importance by showing the XPA peptide inhibits NER.\",\n      \"evidence\": \"Crystal structure of ERCC1\\u2013XPA peptide, anisotropy binding, and cell-free excision inhibition\",\n      \"pmids\": [\"17948053\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structure limited to an isolated peptide\", \"Context within the full complex not captured\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Connected XPA to the global-genome damage-recognition factor DDB2, mapping a C-terminal interaction whose R207G disruption impairs damage recruitment and repair.\",\n      \"evidence\": \"In vitro binding, co-IP, R207G mutagenesis, reconstituted excision, and in vivo recruitment/repair assays\",\n      \"pmids\": [\"19056823\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Temporal handoff from DDB to XPA not fully ordered\", \"Overlap with PAR/TFIIH binding region not yet recognized at this stage\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Established post-translational and circadian control of XPA abundance, identifying HERC2-mediated degradation, SIRT1-mediated deacetylation enhancing repair, and clock-driven oscillation of NER.\",\n      \"evidence\": \"Co-IP, in vitro deacetylation, acetylation-mimetic mutants, HERC2 knockdown, chromatin fractionation, and circadian-time tissue immunoblotting\",\n      \"pmids\": [\"20670893\", \"20304803\", \"21193487\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Upstream signals triggering HERC2 dissociation only partly defined\", \"Tissue specificity of circadian control unexplained\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Identified ATR phosphorylation of XPA at Ser-196 as the switch that stabilizes XPA upon damage by blocking HERC2-mediated ubiquitination, and linked XPA to replication via a PCNA-interacting motif.\",\n      \"evidence\": \"S196A/S196D mutagenesis, co-IP, ubiquitination and chromatin assays; APIM mutagenesis with UV survival/repair and live imaging\",\n      \"pmids\": [\"23178497\", \"23152873\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"APIM/replication role is Medium-confidence single lab\", \"Crosstalk between phosphorylation and acetylation not integrated\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Connected XPA to PARP1 signaling and revealed a non-canonical role: XPA loss drives PARP-1 hyperactivation depleting NAD+/SIRT1 and impairing mitophagy, defining nuclear\\u2013mitochondrial crosstalk.\",\n      \"evidence\": \"PAR-binding mutants, PARP1 activity assays, microirradiation; rescue by PARP inhibition/NAD+ in XPA-deficient cells and C. elegans; RASSF1A complex co-IP and repair assays\",\n      \"pmids\": [\"24953096\", \"24813611\", \"25368379\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"RASSF1A regulation is Medium-confidence single lab\", \"Mechanistic basis of neurodegeneration specific to XPA loss not fully resolved\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Refined the XPA DNA-binding domain to residues 98\\u2013239 and showed it binds Y-shaped ss/ds junctions with full-length affinity, undergoing a DNA-induced conformational change.\",\n      \"evidence\": \"Fluorescence anisotropy and 2D NMR with a C-terminal extension construct series\",\n      \"pmids\": [\"25056193\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional contribution of the extended region in cells not isolated\", \"Conformational change not yet mapped onto complex assembly\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Defined XPA's role in lesion verification by showing it activates TFIIH unwinding of normal DNA but inhibits Core7 helicase at bulky lesions, forming a tripartite verification system with XPC and TFIIH.\",\n      \"evidence\": \"Reconstituted ten-subunit TFIIH/Core7 ATPase and helicase assays with defined lesions\",\n      \"pmids\": [\"26384665\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural arrangement of XPA within TFIIH not yet visualized at this stage\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Resolved the two-surface architecture by which XPA organizes RPA (XPA-N/RPA32C and XPA-DBD/RPA70AB), folding the NER bubble into a U-shape required for activity.\",\n      \"evidence\": \"NMR, SAXS, integrative modeling, and RPA70AB-disrupting mutations with biochemical and cellular NER assays\",\n      \"pmids\": [\"31925419\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Atomic-resolution structure of the assembled bubble not yet available\", \"Role of each contact in assembly order partly inferred\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Assigned distinct functions to the two XPA\\u2013RPA contacts: XPA-N/RPA32C for initial complex association and XPA-DBD/RPA70AB for organizing dual incision, with additive effects when both are disrupted.\",\n      \"evidence\": \"Site-directed mutagenesis with in vitro and cell-based NER assays plus integrative SAXS/NMR modeling\",\n      \"pmids\": [\"35969784\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Precise temporal ordering of incision events not directly observed\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Provided the high-resolution structural mechanism: XPA binds between XPB and XPD and kinks the DNA to reposition the lesion for XPD verification, with the two helicases tracking the strand in opposite directions.\",\n      \"evidence\": \"Cryo-EM of human XPC\\u2013TFIIH\\u2013XPA\\u2013DNA complexes\",\n      \"pmids\": [\"37076618\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Dynamics of lesion handoff to incision not captured\", \"Regulatory modifications not visualized in the structure\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How XPA's regulatory modification network (HERC2/ATR/SIRT1/PARP1) is integrated with the structurally defined pre-incision complex to control repair timing in vivo remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No structure of modified XPA within an assembled complex\", \"Quantitative ordering of regulation versus assembly steps in cells undefined\", \"Mechanistic basis of XPA-specific neurodegeneration via mitochondrial crosstalk incomplete\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 7, 13, 15, 27]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [2, 4, 8, 9, 30, 31]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [25, 28]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [38, 11]},\n      {\"term_id\": \"GO:0000228\", \"supporting_discovery_ids\": [22, 23]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [2, 4, 28, 30, 32]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [33, 23]},\n      {\"term_id\": \"R-HSA-9909396\", \"supporting_discovery_ids\": [21]}\n    ],\n    \"complexes\": [\n      \"NER pre-incision complex\",\n      \"XPA\\u2013RPA complex\",\n      \"XPA\\u2013ERCC1\\u2013XPF complex\",\n      \"XPC\\u2013TFIIH\\u2013XPA\\u2013DNA complex\"\n    ],\n    \"partners\": [\n      \"ERCC1\",\n      \"RPA70\",\n      \"RPA32\",\n      \"TFIIH\",\n      \"DDB2\",\n      \"SIRT1\",\n      \"HERC2\",\n      \"PARP1\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}